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C H A P T E R 
INTRODUCTION 
1.1. RESPIRATION 
1.1.1. Historical retrospect. 
The cytochromes шеге discouered in 1886 by MacMunn, a 
Scottisch physician, who obserued by means of a hand spec­
troscope a neu type of compounds having a characteristic 
absorption spectrum and luidely distributed in tissues (l). 
He called them "histo"- and "myohaematins", since they 
seemed to him to be related to heme and hemin. Hoppe-Seyler 
(1890) and Leuy (1889) opposed the claim of Macflunn, because 
they believed the myohaematins to be identical with myo­
globin (2, 3). 
In 1925, Keilin, studying the respiration of insects, 
demonstrated the validity of the earlier observations of 
WacMunn, but pointed out that the pigments шеге not simple 
haematin compounds but heme proteins, uhich he called cyto­
chromes (A). Keilin established that their reversible redox 
reactions are crucial steps in the cell respiration, and 
classified the cytochromes as a, b and с depending on the 
position of their absorption maxima: a absorps at the long­
est mavelength and с at the shortest. 
Keilin also postulated the existence of a respiratory 
"chain", in uhich cytochrome b is closest to the substrate 
side and a CO- and CN-sensitive enzyme links the cytochromes 
to 0 ? (5). He called this enzyme "cytochrome oxidase" (6). 
Keilin did not believe that cytochrome oxidase шаз a cyto­
chrome or even a heme protein. 
In 1925 Uarburg discovered that cells contain an iron 
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compound - Atmungsferment - which in its bivalent state 
reacts with oxygen and passes into a higher valency state, 
and in 1926 he proved the heme-protein nature of this iron 
compound (7, θ). Not until 1938, Keilin and Hartree showed 
that cytochrome oxidase was identical with Warburg's At­
mungsferment, which is nou called cytochrome aa, (9, 10, 
11). 
1.1.2. Mitochondrial respiratory chain. 
The mitochondrial respiratory chain is a large mul-
tienzyme complex which transfers reducing equivalents from 
the substrates to molecular oxygen through a series of re­
dox reactions. 
It consists of various types of oxidation-reduction compo­
nents: pyridine nucleotide - containing enzymes, flavopro-
teins, quiñones, iron - sulfur proteins, heme proteins and 
copper proteins (12). 
All these components are associated with or located in the 
mitochondrial inner membrane. 
When it is treated with salts and detergents, the pro-
tein-lipid interactions are broken and the respiratory 
chain segregates into five complexes: complex I (NADH dehy-
drogenase); complex II (succinate dehydrogenase); complex 
III (cytochrome be- complex); complex IV (cytochrome c-
oxidase) and complex \1 (ATPase) (13). The isolated cyto-
chrome bc1 complex appears to be roughly spherical, 7.5 to 
9.0 nm. in diameter, with a molecular weight of about 
250.DDO (14). Cytochrome c-oxidase is of similar dimensions 
and molecular weight (15, 16). 
It contains two heme moieties (a and a,) and two copper 
atoms. Upon treatment of this complex with sodium dodecyl-
sulfate, it dissociates in seven subunits (17). 
The electron transfer between the be- complex and 
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cytochrome c-oxidase is mediated by a small globular pro­
tein: cytochrome с. Τωο cytochrome с molecules are present 
for each oxidase complex in intact mitochondria (18). Cyto­
chrome с is not a membrane protein. It is found in the 
space betueen the inner and outer mitochondrial membrane. 
CYTOSOL 
OUTER MEMBRANE 
INTER MEMBRANE SFACE 
IN№R MEMBRANE 
02*uf*4¿ 2H¿0 
MATRIX 
Fig. 1.1.2. Diagrammatic representation of the 
arrangement of some components of the mitochon-
drial electron transfer chain. 
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Fig. 1.1.2. shoujs a model of the spatial arrangement of 
complex III and complex IV in the mitochondrion; both are 
embedded in the phospholipid bilayer inner mitochondrial 
membrane. Several experiments proue such a localisation 
for the oxidase (19) but no comparable information is auai 
lable as yet for the cytochrome be., complex (13). 
The electrons are transferred either from complex I 
or complex II, located at the matrix side of the membrane, 
to the be, complex. It is generally accepted that cytochro 
me c. is the direct donor of the electrons to the cytochro 
me с molecule (17). Subsequently, the electrons are passed 
from cytochrome с to cytochrome a and uia a copper atom 
to cytochrome a-, and the second copper atom, after which 
they are taken over by oxygen at the matrix side of the 
inner mitochondrial membrane. 
1.1.3. Oxidative phosphorylation. 
During the transition of resting, relaxed muscles int 
tense, active muscles, the electron transfer rate in the 
mitochondrial respiratory chain of skeletal muscle cells 
increases by a factor of about one hundred (20). Obvious­
ly, the process of electron transfer is coupled to the 
process of ATP synthesis (oxidative phophorylation). This 
can be understood by considering that in the transfer of 
reducing equivalents from a substrate to oxygen electrons 
descend down along an electrochemical potential gradient; 
the free energy liberated in the redox reactions can be 
used in ATP synthesis (13). 
Three large drops in free energy occur uiithin the 
complexes I, III and IV, respectively, making them the 
principal candidates for sites where ATP is synthesized. 
The validity of the model is substantiated by several ex­
perimental data: 
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The oxidation of one molecule of IMADH, starting in com­
plex I, yields three molecules of ATP, but oxidation of 
succinate, starting in complex II, yields only two mo­
lecules of ATP. Thus phosphorylation site 1 must be lo­
calized within complex I. 
The oxidation of one molecule of IMADH, after blocking of 
cytochrome с oxidase with HCN, yields only tuo molecules 
of ATP. Therefore phosphorylation site 2 must be present 
within complex III and phosphorylation site 3 within 
complex I\l (13, 21). 
ese phosphorylation sites are indicated in fig. 1.1.3. 
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Fig. 1.1.3. The sequence of reactions in the mito­
chondrial respiratory chain, showing phosphorylation 
sites 1, 2 and 3. 
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The proper functioning of an eukaryotic cell depends 
critically on correct regulation of its respiration. The 
mechanism of control is one of the most important aspects 
of eukaryotic electron transfer. The electron transfer is 
completely regulated by the need for ATP synthesis, and 
failure of this respiratory control can lead to severe 
pathological situations, such as a fatal increase of the 
body temperature (17). 
1.2. CYTOCHROME С 
1.2.1. Isolation and amino acid sequence. 
Since Keilin (6) obtained cytochrome с for the first 
time in crude form from Delft yeast in 1930, a large amount 
of information about this protein has accumulated (22). 
Early data concerned the registration of the very characte­
ristic absorption spectrum uith a. Sand γ bands, and the 
determination of the heme iron content (11). 
In 1938 Theorell established that the heme prosthetic 
group шаз coualently attached to the protein backbone by 
two thioether linkages (23) and in 1941 Theorell and Akesson 
gave the first extensive description of some physicochemi-
cal properties of the heme protein, such as: the pH depen­
dence of the optical properties of the protein and of some 
of its derivatives, the magnetic properties of the ferri 
and ferro forms, acid-base titration curves and heats of 
ionization (24), Purification of cytochrome с in a very 
pure form шаз not achieved until the introduction of cation-
exchange chromatography in 1950 (25). The exact iron con­
tent of cytochrome c, isolated and purified in this manner 
from mammalian heart muscle, шаз found to be 0.45^, corres­
ponding to a molecular weight of 12.400. 
The first crystallized protein was obtained from King 
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penguin muscle by Bodo in 1955 and shortly afteruards from 
a wide variety of other sources (26, 22). 
The first complete amino acid sequence of a cytochrome 
c, viz., that isolated from horse heart, was determined in 
1961 by Clargoliash (27). Fig. 1.2.1. shows the sequence of 
the 104 amino acid residues occurring in this compound. 
1 . A c - G l y - A s p - V a l - G l u - L y s - G l y - L y s - L y s - I l e - P h e -
-HEME 1 
1 1 . 
2 1 . 
3 1 . 
4 1 . 
5 1 . 
6 1 . 
7 1 . 
8 1 . 
9 1 . 
1 0 1 . 
V a l - G l n - L y s - C y s - A l a - G l n - C y s -
G l u - L y s - G l y - G l y - L y s - H i s - L y s -
A s n - L e u - H i s - G l y - L e u - P h e - G l y -
G l y - G l n - A l a - P r o - G l y - P h e - T h r -
A l a - A s n - L y s - A s n - L y s - G l y - I l e -
G l u - G l u - T h r - L e u - C l e t - G l u - T y r -
P r o - L y s - L y s - Т у г - I I e - P r o - G l y -
I l e - P h e - A l a - G l y - I l e - L y s - L y s -
A r g - G l u - A s p - L e u - I l e - A l a - T y r -
A l a - T h r - A s n - G l u - O H 
H i s -
Thr-
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T h r · 
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•Thr-Ual-
-Gly-Pro-
• Lys-Thr-
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-Trp-Lys-
-Glu-Asn-
-Lys-Met-
•Thr-Glu-
-Lys-Lys-
Fig. 1.2.1. Amino acid sequence of horse heart cyto­
chrome c. 
At present the amino acid sequences of over 80 cytochromes 
с are known (22). This information represents by far the 
most abundant taxonomie coverage of any protein. The ami­
no termini of cytochromes с from vertebrates and high plants 
are acetylated in contrast to the cytochromes с of most 
lower organisms (28). 
From the sequence of horse heart cytochrome с it 
appears, that it contains nineteen lysyl- and two arginyl 
residues. The residues give the protein a basic character 
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because there are only nine glutamyl-, three aspartyl- and 
tuo heme propionic acid residues present, insufficient 
to neutralize all basic amino acids. 
In the family of кпошп sequences of cytochromes c, 23 
residues are completely invariant (22). To them belong 
some amino acid residues concerned in the heme attachment 
17 1 Я RH 
(Cys ), the iron-ligation (His , net ), or the structure 
maintainance (Pro30· 7', ' 7 B, Gly 6' 2 9' 3 A) and several hydro­
phobic residues which are located close to the heme in the 
, ,. , , ,. 32,68
 n
, 10,82
 x
 48 - 59ч tertiary structure (Leu ' , Phe » , Туг , Тгр ), 38 91 7379\ but also basic (Arg ' , Lys ' ) residues some of which 
are at larger distance from the prosthetic group (22). The 
lysines 8,13,27,39,53,72,88,87 and 99 are not completely 
invariant but rather generally occurring. A number of these 
positively charged residues is thought to be of importance 
for the interaction with cytochrome c-oxidase (22). 
1.2.2. Three-dimensional structure. 
Since the first three-dimensional structure determina­
tion of horse heart cytochrome с in 1971 by Dickerson et al. 
(29), six other cytochrome с structures have been studied. 
By this, the structures of three eukaryotic and four pro-
karyotic cytochromes с are now known. 
The oxidized forms of horse and bonito cytochromes с 
have been determined at 2.В Д resolution (29); and both 
the oxidized and reduced form of tuna cytochrome с have 
been studied at 2.0 H resolution (30,31,32a) and refined 
at 1.8 Я and 1.5 Я, respectively (32b). The structure of 
cytochrome c_ from the photosynthetic prokaryote Rhodo-
spirillum rubrum has also been determined in the oxidized 
and reduced state at 2.0 Π resolution (33). Finally, the 
structures of the oxidized forms of cytochrome c-550 from 
the denitrifying bacterium Paracoccus denitrificans (ЗД), 
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of cytochrome c-551 from Pseudomonas aeruginosa (35) and of 
cytochrome c-555 from Chlorobium thiosulfatophilum (36) 
шеге determined uiith resolutions of 2.5 д, 2.0 Д and 2.7 Ά, 
respectiuely. 
All these X-ray structures show a close similarity. 
The folding of the protein chain can be seen as an enve­
lope, surrounding the prosthetic group. This prosthetic 
group in cytochrome с is a protoporphyrin in uhich, as 
shown in fig. 1.2.2.1., the uinyl side chains haue under­
gone electrophilic addition by the cysteinyl residues 1A 
and 17 leading to thioether bonds with the protein. 
Fig. 1.2.2.1. The heme 
prosthetic group in 
cytochrome c. 
юн cr^OH 
Only a part of the heme group (the edges of pyrrole rings 
2 and 3) are at the protein surface. Fig. 1.2.2.2. repre­
sents the three dimensional structure of horse heart 
cytochrome c, shoujing the exposed heme edge. 
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Fig. 1,2,2,2, Three-dimensional structure of 
horse heart cytochrome с (reproduced from (28) 
with permission, Dr, R,E, Dickerson), 
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A part of the N-terminal sequence of the polypeptide 
chain covers the right surface of the heme group, uihereas 
the remainder of the polypeptide chain envelops the left 
surface and forms the back of the molecule. The axial li-
gands of the heme group are the imidazole residue of his-
tidine-18 at the right side and the sulfur atom of methio-
nine-80 at the left side. The absorption band uiith Ιου 
extinction coefficient at 695 nm originates from this iron-
sulfur ligation (37). The propionic acid side chain of 
pyrrole ring 4 is held in the hydrophobic heme crevice by 
hydrogen bonds with Ьугазіпе-4 and tryptophan-59. The 
тзге exposed propionic acid on pyrrole ring 3 is hydrogen 
bonded with threonine-49 and -78 (28). There are four 
α-helical segments, the largest of which are the N-termi­
nal and C-terminal helices 1-12 and 8Э-101. The other 
helical parts occur at residues 50-55 and 60-68 (38). The 
overall structure is that of a typical water soluble pro­
tein with nearly all the hydrophobic side chains in the 
interior and the hydrophylic residues on the outside. 
1.2.3. Mechanisms of electron transfer. 
Until пот it is not knoun whether the cytochrome с 
molecule must diffuse or rotate to accept electrons from 
cytochrome c1 and transfer them to cytochrome c-oxidase. 
The presence of a tight binding between cytochrome с and 
the oxidase has been conceived as an index that such motions 
do not occur and that the cytochrome с molecule is most li­
kely fixed in a complex together with the oxidase and cyto­
chrome c,. in which a so called "solid-state" mode of elec­
tron transfer through cytochrome с may occur (39). 
The pathway which the electron should traverse through 
cytochrome с in the mitochondrial enzyme system has not yet 
been established. Two detailed electron transfer mechanisms 
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haue been proposed in which the protein part of the mole­
cule : s inuolved. 
The first mechanism uas formulated by Dickersor, 
Uinfield and Takano (40, 41). It is based on the inuarian-
cy of three aromatic rings at the left side of the heme 
group. In the structure of the oxidized protein, tyrosine-
74 is parallel to tryptophan-59 and the authors suggested 
that the electron from the reductase might be passed through 
those two parallel aromatic rings via ir-cloud overlap. In 
a subsequent conformational change, the ring of tyrosine-
74 rotates by 90° and the rings of tryptophan-59 and ty-
rosine-57 become parallel. The electron might then be trans­
ferred via tyrosine-67 to the heme prosthetic group and 
eventually to the iron atom. The oxidation step uas suppo­
sed to occur by transfer via the exposed heme edge. 
The discovery that tyrosine-74 as шеіі as -67 are re­
placed by phenylalanines in some species was not incompa­
tible with this reduction mechanism but when a leucine re­
sidue шаз found at position 74 in Paracoccus denitrificans 
cytochrome c-550 the hypotheses could not uell be main­
tained (2 ). 
The second mechanism, advocated by Salemme, Kraut 
and Kamen, шаз at first intented only for Rhodospirillum 
rubrum cytochrome c^ but later extended to other cyto­
chromes с (42, 43). 
This c^-mechanism postulates a network of hydrogen 
bonds between serine-89, tyrosine-52 and tyrosine-70. 
Essential is that only two protons are available in the 
oxidized protein structure for the three oxygen atoms 
involved, so that a partial, negative charge is created 
on the tyrosine-70 oxygen atom. The positive charge of the 
oxidized iron atom, partially delocalized on the sulfur 
atom of methionine-BO, can then be stabilized by the par­
tial, negative charge on tyrosine-70. Reduction is envi­
sioned as a simultaneous donation of an electron from the 
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reductase to the iron atom and a proton from the medium 
to serine-89. This reshifts all the relevant hydrogen 
bonds and stabilizes the reduced state of the iron atom. 
Oxidation should be the reverse process. Tyrosine-52 is 
not at all conservative, houever. In Paracoccus denitrifleans 
cytochrome c-550 the position 52 is occupied by an iso-
leucine residue, in three other c_ cytochromes from rhodo-
pseudomonads by an isoleucine, asparagine and a methio­
nine residue, respectively. This makes the c_-mechanism 
unlikely for cytochrome с electron transfer (28). 
In addition to these protein-involved mechanisms, turn 
other mechanisms have been proposed in which the protein 
does not participate in the oxidation or reduction (38). 
One of them was developed by Chance to explain the 
temperature independence of the rates of the electron 
transfer reactions (mainly in photosynthesis) (44). After 
complexation of the cytochrome с molecule uith the oxidase 
and reductase, the electron transfer from the donor to the 
acceptor is supposed to occur via quantum-mechanical tunne­
ling. The only function of the protein is to guarantee a 
proper complex uith the redox partners, in order to maxi­
mize the transition probality for transfer of an electron 
between the iron centers. 
The other mechanism focusses attention on the occu­
rence of a heme moiety in cytochrome с and both his redox 
partners. Electron transport from iron to iron is supposed 
to occur via a π-system, formed by lateral orbital over­
lap between the porphyrin ir-clouds of cytochrome с and 
the partner at the exposed heme edge of cytochrome с (38). 
At this time the supposition that the presence of an 
exposed heme edge in cytochrome с plays an important role 
in electron transport is rather generally accepted (22). 
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1.3. SEWISYNTHESIS. 
1.3.1. Introduction. 
The information on hou to make a particular protein 
is stored in the living cell as a coded sequence of or­
ganic bases along a molecule of DNA (RNA in some Іошег or­
ganisms). This linear information is translated into a 
linear sequence of amino acids. Proteins, however, have a 
шеіі defined three-dimensional structure and in most cases 
the biological function of enzymes is completely dependent 
on these very specific conformations. The specific folding 
of a linear amino acid polymer is determined entirely by 
the kind and distribution of the amino acid side chains. 
In order to reveal which side chains (or parts of side 
chains) are important for the folding and what are the im­
plications of tertiary structures for biological functions, 
it is useful to study proteins in which amino acid side 
chains have been specifically modified. Chemical synthesis 
of polypeptides is the method of choice to obtain such 
sequence modified derivatives. 
Many successful methods have evolved for the total 
synthesis of a wide variety of small and even modestly si­
zed peptides, synthesized during the 19503 and 196Ds. Im­
portant peptides include: oxytocin (1954) (45), angioten­
sin I (1957) (46), ß-MSH (1963) (47), ACTH (1963) (48), 
insulin (1963) (49), gastrin (1964) (50), glucagon (1967) 
(51), secretin (1967) (52), calcitonin (196 ) (53). 
Yet, several methodological shortcomings in the avai-
lable methods come to the light, as soon as the size of the 
polypeptide becomes larger than, for example, that of in-
sulin. Problems, such as; restricted purity of intermedi-
ates and decreasing in solubility of growing protected 
peptide fragments, incomplete final deprotection of large 
protected derivatives (often with liquid HF) and especially 
22 
the unsatisfactory coupling of large protected fragments, 
make total synthesis of large polypeptides generally diffi­
cult, time-consuming and often impossible (54, 55). Some 
syntheses haue been reported for real proteins such as 
ribonuclease (56) and cytochrome с (57), but they are un­
attractive for routine application, as is necessary for the 
synthesis of analogues. In order to ouercome some of the 
difficulties mentioned, semisynthesis has evolved in the 
last 5 - 1 0 years as an alternative to the completely che­
mical synthesis of peptides and especially proteins. 
1.3.2. Classification. 
Semisynthesis of proteins can be defined as a proce­
dure uhich involves the use of fragments, isolated from 
naturally occurring compounds together with one or more 
synthetic compounds, in the production of a protein or 
protein derivative. The final reconstitution of the com­
ponents to a complete polypeotide or polypeptide system 
can be either covalent or noncovalent. Formally, at least 
one пеш peptide bond must be formed between a synthetic 
peptide or an amino acid derivative and an isolated pro­
tein fragment, to make this definition applicable. This 
definition provides a basis for a classification of semi-
synthesis viz. in stepuise semisynthesis and fragment 
condensation semisynthesis (58). 
a, stepuiise semisynthesis. 
The first stage in the stepwise approach is the removal 
of a peptide fragment or an amino acid residue (generally 
from the amino-terminal end) from a completely ε-amino-
protected polypeptide. This provides a C-terminal sequence 
having a free α-amino group at the end of the polypeptide 
chain. This free α-amino group is the only one available 
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for coupling ujith a protected and activated amino acid 
derivative. 
Active ester condensations are frequently employed 
for the stepuise addition of single amino acid derivatives 
at the amino termini of l\l£-protected protein fragments (55). 
Semisynthetic protein fragments, obtained in this way, 
can be used for the noncovalent or covalent reconstitution 
of functional polypeptides by respectively complexation 
or fragment condensation uith another native or(semi)syn-
thetic polypeptide, 
b. fragment condensation semisynthesis. 
For the fragment condensation approach coupling is required 
between a synthetic protein fragment and a fragment isola­
ted from a natural source. In this mode of semisynthesis, 
a differential protection of the side chain carboxyl groups 
is, generally necessary, in order to ensure solely activa­
tion of the a-carboxyl group. This selective activation 
of the a-carboxyl group constitutes one of the greatest 
problems in this type of semisynthesis (54,55,58). Τωο spe­
cific examples are кпошп in which selective activation of 
the a-carboxyl group could be achieved without protection 
of the side chain carboxyl functions. 
One of them is based on the fact that cyanogen bro­
mide cleavage of a methionine containing protein produces 
a fragment with a C-terminal homoserine-lactone residue 
which can undergo spontaneous and completely specific pep­
tide bond formation with a complementary amino component 
without side chain protection of either of them, at least 
if the fragments are arranged in a three-dimensional struc­
ture which is very similar to that of the native protein 
(59, 60). 
The other example of specific a-carboxyl activation 
is met when fragments, obtained by hydrolysis of a protein 
with a proteinase, can be coupled by reversal of the action 
of the proteolytic enzyme (61). In this case side chain 
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protection can also be restricted or even omitted. 
1.3.3. Selected examples. 
The definition of semisynthesis given in I.3.2., ex­
cludes reactions betujeen a protein and a synthetic reagent 
not derived fromamino acids-acetylation of trypsin uould 
be an example (54) - but also formation of species from a 
synthetic peptide and an isolated protein fragment without 
the formation of a covalent peptide bond, such as the pre­
paration of ribonuclease S by association of the "natural" 
S-protein with a synthetic S-peptide or the combination of 
the natural insulin Α-chain ujith a synthetic B-chainf or 
vice-versa (62, 63). 
Ноше ег, substitution of B1-phenylalanine by (3,5 -
dijodo)-tyrosine, after one cycle of Edman degradation uiith 
N01 -, [\Ιε -bis-Msc-insulin is a typical example of a 
stepwise semisynthesis (64). Stepwise semisynthesis can also 
be performed at the C-terminal side of protein molecules, 
which is illustrated by the conversion of porcine insulin 
into human insulin which differs only in the C-terminal 
amino acid of the B-chain. The C-terminal B3D-alanine of 
porcine insulin could be removed by treating the molecule 
with carboxypeptidase A and the des-B3G-alanyl-insulin was 
converted into human insulin by an enzymatic coupling with 
a partially protected threonine derivative, followed by 
cleavage of the protecting groups (65). 
Two examples of semisynthesis are known in which the 
transformation of a methionine residue into a homoserine 
lactone residue plays a crucial role. Basic pancreatic 
trypsin inhibitor, which contains 5B amino acid residues, 
can be cleaved specifically by cyanogen bromide after 
methionine-52, converting it into a homoserine lactone re­
sidue. The two fragments are held together by a disulfide 
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bridge and the three-dimensional structure of the cleaued 
molecule is very similar to that of the natural compound. 
By this a peptide bond is formed spontaneously between the 
lactone and the adjacent arginine residue, restoring the 
intact polypeptide chain intramolecularly, whilst methio-
nine-52 is replaced by homoserine (55, 66). 
A comparable condensation experiment has been perfor­
med intermolecularly with cytochrome c, which does not con­
tain disulfide bridges. Under appropriate conditions, it 
is possible to couple two cyanogen bromide fragments, cor­
responding to the sequences 1-65 and 66-1D4, re-establishing 
a complete sequence with homoserine replacing methionine-65 
(67). This spontaneous resynthesis has euen been used to 
combine 1-65 and 66-1Q4 fragments, originating from cyto­
chromes of different species (6B). In order to obtain spe­
cifically modified cytochrome с analogues, synthetic (69, 
7D) and semisynthetic (71,72,73,74,75) fragments 66-104 
have also been employed. 
1.4. COMPLEXES OF PROTEIN FRAGMENTS 
1.4.1. General. 
Several proteins can be cleaved enzymatically or che­
mically into large fragments that, after separation, can be 
recombined to form a functioning noncovalent complex. The 
tertiary structure of such complexes, determined comple­
tely by hydrophobic interactions, hydrogen bonds and dipo­
lar or ionic forces between the protein fragments, is often 
sufficiently similar to that of the native protein, to en­
dow them with a significant, though often reduced, biolo­
gical activity. 
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1.4.2. Examples. 
Since the discovery of Richards in 1958 that bovine 
pancreatic ribonuclease can be converted by limited diges-
tion with subtilisin, into a biologically active derivative 
consisting of two fragments that are held together by non-
covalent interactions, noncovalent two or even three frag-
ment complexes, of five other proteins have been described. 
In table 1.4.2. these proteins and the derived complexes 
have been collected. 
In some studies natural fragments of complexes mentio-
ned in table 1.4.2. have been replaced by equally composed 
synthetic or semisynthetic fragments, or fragments contai-
ning specific modifications. Synthetic RNase S-peptide has 
been recombined uith native RNase S-protein (62, 63, 93). 
In the complexing systems derived from nuclease, synthetic 
fragments 6-47 and 99-149 have been used (94, 95) and in 
the human somatotropin complementing system, the fragment 
141-191 has been replaced by a synthetic fragment 140-191 
(96). 
In the complexes (1-38) : (39-104) and (1-38) : (59-
104), both derived from cytochrome c, the lysyl residue 
-39 and tryptophyl residue -59, respectively, have been sub-
stituted by analogues via a stepuise semisynthetic proce-
dure (83, 88). 
The latter modifications of fragments, present in 
complexing systems, by synthetic or semisynthetic operations, 
prior to noncovalent complexation, permit examination of 
the importance of the modified residues for the maintainan-
ce of the protein folding and/or the biological function. 
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Table 1.4.2.: Noncoualent protein fragment complexes, 
described in literature. 
Protein Deriwed complex Cleavage method Reference 
Pancreatic-
RNase ( 
Staphylococ­
cal Nuclease 
Cytochrome с 
1-20):(21-124) 
1-12D):(111-124) 
1-118):(1Q5-124) 
;Б-4 ):(49,50-149) 
,1-126):(49,50-149) 
;ΐ-126):(99-149) 
,1-65):(66-104)a· 
1-53):(54-104)Ь· 
1-38):(3g-104)c· 
і-за):(і-і04) 
1-65):(1-ΐα4) 
,1-В0):(1-104) 
:i-3B):(56-104)b· 
J-25):(23-104)b· 
J-З ): (39-104) 
;i-25):(28-З ):(56-104)Ь· 
;i-38):(59-104) 
subtilisin 
pepsin 
pepsin, 
carboxyp 
trypsin 
trypsin 
trypsin, 
CNBr 
trypsin 
trypsin 
trypsin 
CNBr 
CNBr 
trypsin 
trypsin 
trypsin 
trypsin 
trypsin, 
trypsin, 
eptidases 
CNBr 
DMSO/HBr 
1958, 
1970, 
1978, 
1967, 
1969, 
1971, 
1974, 
1977, 
1977, 
197 , 
197 , 
1979, 
1980, 
19 1 , 
Richards (76) 
Lin (77) 
Andria (7B) 
Taniuchi (79) 
Taniuchi (BO) 
Taniuchi (81) 
Corradin (67) 
Hantgan (82) 
Harris (83) 
Wilgus (84) 
11 
11 
Parr (B5) 
II 
Westerhuis ( 6) 
Juillerat (87) 
Idesterhuis (88) 
Table 1.4.2 (continued) 
Protein Derived complex Cleavage method Reference 
1972, Holmgren (89) 
1975, Slaby (90) 
II 
1976, Li (91) 
1978, Hagenmayer (92) 
Escherichia 
Coli Thio-
redoxin 
Human Soma-
totropin 
Myoglobin 
(1-37) :(38-1Q8) 
(1-73):(74-108) 
(l-73):(38-108) 
(1-134):(l41-19l)d· 
(l-55):(32-139) 
CNBr 
trypsin 
trypsin, CNBr 
plasmin 
trypsin, CNBr 
a. only if the heme peptide is in the reduced state. 
b. complexes derived from overlapping complexes by proteolysis. 
c. lysyl residues are acetimidylated. 
d. cysteinyl residues are carbamidomethylated. 
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1.5. AIM OF THE INUFSTIGATIONS 
As outlined in the preceding sections of this chapter 
specific replacements of amino acid residues in proteins 
can best be done wia semisynthetic procedures. In our group 
the modification of euolutionary invariant or almost in­
variant residues in horse heart cytochrome с is the main 
interest. The introduction of M -acylated lysyl residues 
at one, tiiio or three of the positions -72, -73 and -79, 
normally taken by lysyl residues, and the substitution of 
a tyrosyl residue -67 or -74 by leucine have already been 
realized via a semisynthetic procedure uihich involves the 
"conformation-directed" acylation of the glutamic acid re-
sidue-66 in a fragment 6Б-104, by the homoserine-lactone 
residue-65 in a fragment 1-Б5, as the last and crucial step 
for the formation of covalent cytochrome с analogues(67,72, 
73). 
The original purpose of the study, described in this 
thesis, uias the development of another procedure for the 
semisynthesis of cytochrome c, luhich should be suitable for 
the preparation of analogues in which the completely inva­
riant tryptophan -59 had been replaced. 
Semisyntheses alujays start uith the fragmentation of 
a protein in order to obtain suitable fragments. Therefore, 
a number of selective protein-cleavage methods uias employed 
to fully amino protected cytochrome с in order to get some 
large and selectively protected fragments (CHAPTER II). 
In CHAPTER III an investigation into the formation 
of a complex betueen the turn complementary tryptic fragments 
1-38 and 39-104 is described. Formation of such a complex 
might be of great assistance in the coupling of the frag­
ments, by guiding together the relevant sites of the com­
ponents; formation of the peptide bond betuieen residues 38 
and 39 was the last step in our scheme for the semisynthe­
sis of analogues of cytochrome c. It turned out that the two 
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tryptic fragments formed a stable, biologically actiwe com­
plex having several physicochemical properties quite simi­
lar to the native protein (SB). 
Ноше ег, preliminary studies indicated that the trans­
formation of the noncovalent complex into the desired co-
valent species could not be realized by condensation methods 
used in peptide synthesis. For that reason a study was made 
of the usefulness of an enzymatic peptide bond formation 
for this fragment coupling (CHAPTER IU). It appeared that 
the method ujorked uell in condensations of fragment 1-З 
uith small synthetic peptides (97) but that the method fai­
led in the coupling of a peptide such as the fragments 39-
1G4 or 39-65. At that time the idea of studying the influ­
ence of substitutions of tryptophan-59 on biological acti­
vities with covalently bonded analogues шаз abandonned and 
the attention шаз directed to the study of such effects in 
molecular complexes composed of tiiio fragments from horse 
heart cytochrome c. 
In connection uith the elucidation of the structure 
of cytochrome C551 from Pseudomonas aeruginosa in which a 
deletion, corresponding to the sequence 39-58 of horse 
heart cytochrome с шаз found (35) the formation, properties 
and biological activity of another molecular complex, com­
posed of the fragments 1-3B and 59-104 have been studied. 
On account of the results obtained this type of complex has 
been used in the further investigations. 
In order to obtain fragments 59-104, a strategy шаз 
chosen which involves the use of the cyanogen bromide frag­
ment 66-104. After elongation with methionine-65, the frag­
ment had to be coupled uith synthetic hexapeptide derivati­
ves, representing the sequence 59-64 in u/hich tryptophan-
59 had been substituted by other residues. In CHAPTER \1 the 
synthesis of such a hexapeptide derivative containing un­
modified tryptophan at position -59 is described. In the con­
tinuation of the study it appeared, houever, that the hexa-
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peptide derivatiue59-64 and the fragment 65-104 could not 
be coupled, although the presence of an active carboxyl 
function in the former could be demonstrated. 
The strategy for the synthesis of suitable fragments 
59-104 шаз therefore modified to a procedure which invol­
ves the use of the fragment 60-104, obtained from cleavage 
of cytochrome с after tryptophan-59, and elongation of this 
fragment uiith tryptophan or another residue. It appeared 
that the unmodified fragment 59-104 formed a stable complex 
uiith the fragment 1-38, having a biological activity compa­
rable to the native protein ((BB), CHAPTER VI). CHAPTER VI 
also contains the preparation of modified fragments 59-104, 
their complexation with the fragment 1-3B and the evaluation 
of the biological activities of these complexes, 
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C H A P T E R II 
ISOLATION AND PURIFICATION OF PARTIALLY 
PROTECTED CYTOCHROME С FRAGMENTS 
II.1. INTRODUCTION 
Previous investigations into the formation of cytochro­
me с analogues, resulted in a strategy in which one frag­
ment which uas produced by an organic synthesis, was inser­
ted betujeen two fragments uhich were obtained from the de­
gradation of native cytochrome c. 
For the application of this strategy, conversion of one 
of the fragments of native origin in an activated form is 
prerequisite. The inserted middle part, containing a desired 
replacement or modification of tryptophan-59 should be syn­
thesized as an activated compound, ensuring a selective acy-
lation of the isolated C-terminal fragment of native cyto­
chrome c. The product of this condensation must then be acy-
lated uith the first mentioned native N-terminal fragment. 
In general, protection of the partial C- and N-terminal 
sequences, at least at side chain amino functions might be 
necessary in such a procedure. The strategy becomes more 
attractive if the natural C- and N-terminal sequences are 
larger; however, chemical and enzymatic methods, intended 
to obtain large fragments from a protein by selective clea­
vages, have to be directed to residues, which occur infre­
quently in the polypeptide chain. In cytochrome с these are 
arginine, methionine and tryptophan. 
In this investigation the applicability of chain frag­
mentation, implying each of these amino acyl groups has 
been studied: 
38 39 
- cleavage of cytochrome с at the arginyl -lysyl 
39 
bond to obtain the fragments (1-38) and (39-1Q4). 
- cleavage of cytochrome с after the methionine resi­
dues at positions B5 and 80, yielding fragments (1-
65), (66-80) and (81-104); or only at position 65, 
yielding the larger fragment (66-104). 
- further cleavage of the fragment (1-65) from the pre­
vious degradation at position 38, giving again the 
fragment (1-38) and the пеш fragment (39-65). 
- cleavage of the latter fragment after tryptophan-59, 
yielding the fragments (39-59) and (60-65). 
- cleavage of cytochrome с at position 59, producing 
the peptide derivatives (1-59) and (60-104). 
In this chapter the enzymatic and chemical methods used for 
these cleavages (see fig. II.1.) are shortly discussed and 
the isolation, purification and characterization (by amino 
acid analyses) of fragments, used in further investigations 
are described. 
Ac-4-
pHEME-| 
Trypsin 
-38-
Arg 
iDMSO/HBr 
zChymotrypsin 
1 I I 
CNBr 
-59-65-
Trp Met 
-104 
Fig. II.1. Schematic representation of cleavage 
sites in cytochrome c. 
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II.1.1. Enzymatic cleavage. 
II.1.1.1. Trypsin. 
Trypsin is a very attractive enzyme for fragmentation 
reactions, because it exhibits the highest degree of sub­
strate specificity of all кпошп endopeptidases. Gnly bonds 
involving the carboxyl groups of lysyl and arginyl residues 
are hydrolyzed. 
Fragmentations with trypsin can be even more restricted 
because polar groups close to a susceptible bond, decrease 
the rate of hydrolysis: e.g. negative charges present in 
the side chains of aspartic acid, glutamic acid or cysteic 
acid tend to reduce the rate of hydrolysis significantly, 
uihen they are adjacent to a lysyl or arginyl residue; the 
sequences -Asp-Lys-Leu- and -Asp-Lys-Ala-, found in the 
Y-chain of human hemoglobin are incompletely cleaved by tryp­
sin under all circumstances and the sequence -Glu-Arg-Glu-, 
found in cytochrome с is not cleaved at all (1, 2, 3, 4). 
Peptide bonds involving the imino nitrogen of proline 
(-Lys-Pro- or -Arg-Pro-) appear also to be entirely resis­
tant to tryptic hydrolysis. Finally, the proteolytic acti­
vity of trypsin can be further restricted considerably by 
masking of aminofunctions in lysineside chains; in that case 
hydrolysis only occurs after arginine residues (l). 
II.1.1.2. Chymotrypsin. 
Although chymotrypsin exhibits a rather broad speci­
ficity, peptide bonds involving the carboxyl groups of ty­
rosine, phenylalanine, tryptophan and leucine are hydro­
lyzed preferentially. Cleavages have also been reported at 
the carboxyl groups of methionine, glutamine, asparagine, 
41 
histidine, threonine, serine, glycine, valine and isoleu-
cine, but the extent of hydrolysis was Ιοω (1). 
Sometimes, the number of chymotryptic cleavage products 
can be reduced by employing a low ratio of enzyme to sub­
strate concentration and a short digestion period. Neigh­
boring groups are known to have a marked effect; the pre­
sence of a basic residue (Lys, Arg or His) adjacent to a 
susceptible bond seems to enhance cleavage at that site 
(5, 6). 
II.1.2. Chemical cleavage. 
II.1.2.1. Cyanogen bromide. 
Of all chemical methods available for the cleavage of 
peptides and proteins at specific amino acid residues, by 
far the most efficient appears to be the cyanogen bromide 
cleavage (7, B). This method owes its success to its speci­
ficity for methionyl residues which are usually rare in 
proteins. 
The reaction involves formation of a sulfonium salt 
adduct between the bivalent sulfur atom of methionine and 
the cyanogen bromide and subsequent nucleophilic displace­
ment of methylthiocyanate by the carbonyl group of the next 
peptide bond (Fig. II.1.2.1.). The resultingiminolactone is 
rapidly hydrolyzed in aqueous acid with concomitant clea­
vage of the peptide chain and formation of a C-terminal 
homoserine lactone residue in the amino terminal part. 
The reaction is usually carried out in 0.1 N HCl or 
70% aqueous formic acid, thus preventing reaction of cyano­
gen bromide with amino groups. The solvent, formic acid also 
ensures unfolding of the protein chain so that the methioni­
ne residues become exposed. 
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Fig. II.1.2.1. Mechanism af cyanogen bromide 
cleavage. 
II.1.2.2. Dimethylsulfoxide-hydrogen bromide. 
Chemical methods for the cleauage of peptides and 
proteins at tryptophyl residues haue been reuieued by Sauige 
and Fontana (9). All procedures are oxidative, employing re-
agents such as periodate, ozone, and particularly bromina-
ting agents. The combination of hydrogen bromide and di-
methylsulf oxide constitutes a favourable procedure for clea-
ving tryptophyl peptide bonds in proteins (10). The pro-
posed mechanism is presented in Fig. II.1.2.2. The trypto-
phan residue is oxidized to an oxindolylalanine residue 
uhich is brominated at C,. Final cleavage occurs as in the 
previous method by formation of an iminolactone and sub-
sequent hydrolysis. In this way an oxindolylalanine spiro-
lactone becomes the C-terminal amino acid of the peptide 
liberated. 
The cleavage procedure is specific for tryptophan, but 
side reactions are the oxidation of methionine to the sulf-
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oxide and cysteine to cystine. In cytochrome с the reaction 
is accompanied by a complete detachment of the heme moiety 
(10). 
о^ут^ъ
 u O^S-NH-
„ 1 DMSO ¿ s ^ - ü s ' Ocx ^QCC 
й й 
DMSO 
HBr 
η O'S' 
-p 
Λο 
NH 
' N H J 
ώ 
I 
h tí 
Fig. II.1.2.2. Mechanism of dimethylsulfoxide-
hydrogen bromide cleavage. 
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II.2. EXPERIMENTAL 
II.2.1. Materials. 
Horse heart cytochrome с was obtained from Sigma Che­
mical Co. (Type Ml), trypsin and chymotrypsin from Boehringer 
Mannheim. Sephadex gels uere from Pharmacia Fine Chemicals, 
and cellulosic ion exchangers (DE-52 and CM-52) from Idhat-
mann Biochemicals. 
II.2.2. General procedures. 
Column eluates шеге monitored uiith an LKB, Uvicord type 
III or type S instrument. Amino acid compositions шеге de­
termined with a modified Jeol JLC-GAM analyzer after hydro­
lysis in 5.7 N hydrochloric acid (Merck, suprapur) for 24 h 
at 110-115oC in sealed, evacuated tubes. 
II.2.3. Protection of side chain amino groups. 
In order to limit the sites of tryptic attack of horse 
heart cytochrome с to arginine peptide bonds and to obtain 
selectively protected protein fragments, the side chain 
amino functions of all nineteen lysine residues шеге pro­
tected with Msc-groups (11), using methylsulfonylethyl 
succinimidyl carbonate (12). 
The absence of unprotected amino groups ujas routinely 
checked by amino acid analyses, after dinitrophenylation. 
When necessary, this compound will be referred to as "pro­
tected cytochrome c". 
A5 
II.2.4. Cleavage of the protein (fragments). 
11.2.4.1. Tryptic digestion. 
Tryptic digestion of the protected cytochrome с or the 
heme-containing cytochrome с fragment (1-65) шаз carried out 
in 0.2 M phosphate buffer pH 6.9 at a substrate concentra­
tion of about 20 mg/ml. Trypsin (1$ in 10~3 N HCl, 20 ul/ 
ml substrate solution) шаз added at zero time, and after 1 
hour at 37 С the digestion шаз stopped by freezing the di­
gest uihich шаз then lyophilized. 
11.2.4.2. Limited chymotryptic digestion. 
Limited digestion of the partially protected cytochro­
me с fragment (39-65) шаз carried out in 0.1 M ammonium bi­
carbonate buffer pH 8.5 at 37 С and a protein concentration 
of 10 mg/ml. Exactly 1 min. after the addition of a solu­
tion of chymotrypsin (1% in 10" N HCl, 30 U1/ml substrate 
solution) the resulting mixture шаз frozen and then lyo­
philized. 
11.2.4.3. Cyanogen bromide cleavage. 
Protected cytochrome с шаз treated viiith cyanogen bro­
mide in 70^ 0 (v/v) aqueous formic acid for 24 h at room tem­
perature in the dark, at a protein concentration of 40 mg/ 
ml using 30 or 3 molar equivalents CNBr (7 mg/ml or 0.7 mg/ 
ml,resp.). The resulting solution was either diluted with 
water to 50% (v/v) formic acid and directly applied to a 
gelfiltration column (see sec. II.2.5.) or diluted to 7% 
(v/v) formic acid and lyophilized. 
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II.2.h,4. Dimethylsulfoxide-hydrogen bromide cleavage. 
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II.2.5. Separation of fragments. 
The lyophilized tryptic digestion mixture of protec-
ted cytochrome с 
acid (ca 
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the same 
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acid urns 
column. 
these so 
The 
chemical 
. 100 mg. 
Sephadex 
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шаз dissolved in 1Q% (v/v) aqueous formic 
of digest/ml) and then applied to a co-
G50-fine which h 
For the separat 
ryptic digestion 
protected heme 
f cytochrome cf 
dissolution, an 
The columns (3.5 χ 140cm) 
Ivents at 
partiall 
dégradât 
rated using a col 
equilibrated and 
a flow rate of 
y protected frag 
ion of protected 
umn of Sephadex 
eluted with 50% 
ad been equilibrated uith 
ion of the lyophilized 
mixtures of, respective-
fragment (1-65) and the 
50% (v/v) aqueous formic 
d equilibration of the 
шеге also eluted with 
30ml/h. 
ments, originating from a 
cytochrome с, шеге sepa-
G50-fine (5 χ 130 cm) 
(v/v) aqueous formic acid 
at a flow rate of 50 ml/h. 
Selected fractions шеге pooled and the peptide deriva­
tives шеге recovered by concentrating the solution in vacuo 
to a small volume (2-4 ml) and lyophilization of this solu­
tion after the addition of water (ca. 100 ml). 
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II.2.6. Purification of fragments. 
The crude fragments, obtained after gelfiltration, 
were purified by ion exchange chromatography on a column 
(14.5 χ 0.6cm) of DE-52 cellulose, using a linear phos­
phate gradient, 4М urea, pH Б.9. Four fractions of 5 ml. 
mere collected per hour. 
In the purification of the larger peptides (1-65), 
(39-104) and (60-104) the gradient consisted of 100 ml 
0.005 M and 100 ml 0.1 M phosphate. For the smaller pepti­
des (39-65) and (39-59) and also (66-104) the gradients 
шеге composed from 100 ml of 0.005 M and 0.05 ΓΊ phosphate, 
whereas for the heme peptide (1-38) only 50 ml portions of 
the latter buffer solutions шеге used. 
Fractions containing a purified peptide deriuatiue 
were freed from urea and phosphate by gelfiltration over a 
column (40 χ 3.5cm) of Sephadex G25-fine in 0.02 ΓΊ ammo­
nium acetate pH 6.5. The peptide derivatives шеге then re­
covered by lyophilization. 
II.3. RESULTS 
The use of Msc-functions for the protection of e-amino 
groups in cytochrome с turned out as succesful. Dinitro-
phenylation of the purified cytochrome с fragments, follo-
ued by amino acid analysis, showed that all lysine side 
chain amino groups remained completely protected during 
the cleavage procedures (table II.3.). Apparently the Msc-
protective function is resistant to digestion by the pro­
teolytic enzymes, trypsin and chymotrypsin, to cyanogen 
bromide degradation and even to the very acidic conditions 
of the dimethylsulfoxide-hydrogen bromide cleavage proce­
dure, It has been shown previously that the Msc-function 
is also stable towards the Edman degradation (13a, 13b). 
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Selectiuely IM -protected protein fragments, which are use­
ful to achieve a semisynthesis of proteins or partial se­
quences of proteins, can thus be obtained by a combination 
of the Msc-protection luith several important protein clea­
vage methods. 
Fig. II.3.1.А, В shows the elution profiles of the 
fission products, following the attack of trypsin on the 
fully amino protected cytochrome с as well as on the amino 
protected heme fragment (1-65), obtained by cyanogen bromi­
de degradation. Only two fragments were obtained since the 
cleavage occurred exclusively at the Arg -Lys (Msc) bond. 
91 92 Cleavage of the Arg -Glu bond was never observed in the 
former case. This in agreement with experiments previously 
described (2, 3, 4). 
Fig. II.3,I.E. shows that short treatment of the l\l -
protected fragment (39-65) with chymotrypsin leads to a 
rather selective splitting at the Trp -Lys (Msc) bond; 
only a small amount of the fragment (39-4Θ) is observed. 
Prolonged treatment with chymotrypsin (16 h.) resulted in 
a further fragmentation of the N -protected peptide deri­
vative (39-65), due to cleavages at the acyl sites of Phe , 
Туг
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, Asn54 and Trp59 (14). 
Fig. II.3.2. shows results of the degradation of the 
fully amino protected cytochrome с derivative with cyanogen 
bromide. Degradation with a large excess (3D equivalents) 
cyanogen bromide (A), leads to nearly complete cleavage 
at both methionine residues (-65 and -80) giving the frag­
ments (1-65), (66-80) and (81-104) in high yield and only 
a small amount of the fragments (1-80) and (66-104). De­
gradation of the protein with a smaller excess (3 equiva­
lents) causes the occurrence of all three possible sequen­
ces (1-104), (1-80) and (66-104) in the reaction mixture 
(B), from which the fragment (66-104) could be isolated 
(15). 
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200 300 
Elution votine (ml ) 
Fig. II.3.1. Separation of the components of enzyma­
tic digestion mixtures of protected cytochrome с or 
cytochrome с fragments. A. tryptic digest of protec­
ted cytochrome c; 1.,(1-104); 2.,(39-104); 3.,(l-38). 
B. tryptic digest of protected (1-65); 1., (1-65); 
2., (1-3Θ); 3., (39-65). C. chymotryptic digest of pro­
tected (39-65); 1., (39-65); 2., (39-59); 3., (39-48). 
Conditions as specified in II.2.5. 
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1500 1700 1900 2Ю0 
Fig. II.3.2. Gel filtration of the fragments from 
a degradation of protected cytochrome с with 30 eq. 
(A.) or 3 eq. (B.) cyanogen bromide. 1., sequence 
(1-104); 2., fragment (1-80); 3., fragment (1-65); 
4., fragment (66-104); 5., fragment (Θ1-104); 
6., fragment (66-80). 
Upon treatment of protected cytochrome с with dime-
thyl-sulfoxide and hydrogen halides, the single trypto-
phyl bond was cleaved, affording the fragment (60-104) in 
58$ yield. Side reactions are the conversion of both methio­
nine residues to the corresponding sulfoxides and the de-
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taqhment of the heme group. From Fig. II.3.3. it appears 
that the oxidized, partially protected fragment (60-104) 
can шеіі be separated from the uncleawed but oxidized, pro­
tected apocytochrome с and from the oxidized, protected 
apofragment (1-59) by golfiltration. The шеіі resolved 
peaks are preceded by some presumably aggregated material 
(10). The home group and further degradation products are 
eluted at ca. 2500 ml. together with the phenol, which acted 
as a scauenger against bromination of tyrosine. 
ц2в0пт 
1000 1200 
Elution volume (ml J 
1400 
Fig. II.3.3. Gelfiltration of the fragments from a 
degradation of protected cytochrome с with dimethyl-
sulfoxide and hydrogen bromide. 1., sequence (1-104); 
2., fragment (1-59); 3., fragment (60-104). 
In most cases the crude fragments isolated after gel-
filtration appeared already nearby homogeneous (Fig. II.3.4, 
a.-g.). M n o r contaminants could be removed by ion exchange 
chromatography on a positively charged support. 
The crude fragments (1-65) and (39-65) are clearly 
composed of two components (Fig. II.3.4. b. and f.). Both 
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Fig. II.3.4. Elution patterns of DE-cellulose 
chromatography of partially protected cytochrome 
с fragments: a., (1-38); b., (39-65);c.t (66-104); 
d., (39-1G4). 
partial sequences originate from a cyanogen bromide degra­
dation, and the components must be the fragment having a 
C-terminal homoserine lactone residue and the same fragment 
in uhich the lactone has been hydrolyzed. This appears from 
amino acid analyses after dinitrophenylation of the indi-
widual components, separated by ion exchange chromatogra­
phy, which gaue equal values for both components (table 
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II.3.). After remowal of the flsc-groups from the mixture of 
two components by a short alkali treatment, it behaved as a 
single entity in ion exchange chromatography, because the 
lactone ring is hydrolyzed completely in the base solution. 
2 0 п т 
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Fig. 11,3.4. Elution patterns 
of DE-cellulose chromatography 
of partially protected cyto­
chrome с fragments: 
е., (60-104) 
f., (1-65) 
д., (39-59) 
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Fracton nijnber 
54 
Table II.3.: Amino acid analyses of some cytochrome с fragments. 
F 
Residue (1-
Asp 
Thr 
Glu 
Pro 
Gly 
Ala 
Mai. 
Met1" 
H e 
Leu 
Туг 
Phe 
NH, 
Lys"* 
His 
Arg 
2.01 
1.81 
4.25 
1.02 
7.17 
1.05 
2.72 
-
0.92 
1.93 
-
1.89 
4.67 
7.37 
2.95 
0.97 
ragmen 
38) 
b 
2.06 
1.77 
4.09 
1.00 
7.16 
1.13 
2.80 
-
0.95 
1.93 
-
1.96 
5.16 
7.02 
1.65 
0.92 
t 
(39-
3.01 
4.58 
4.00 
0.99 
3.06 
2.00 
-
-
0.97 
1.00 
1.07 
1.00 
3.81 
3.90 
-
— 
65) c 
b 
3.03 
4.30 
3.71e 
1.03 
3.03 
2.10 
— 
_ 
0.95 
0.96 
-
0.94 
4.21 
2.85 
-
-
(39-
3.06 
4.63 
3.71 
1.07 
2.98 
1.98 
-
-
0.99 
1 .03 
1.05 
1.00 
4.76 
3.91 
-
-
65) d 
b 
3.01 
4.56 
3.92e 
1.05 
3.01 
1.97 
-
-
0.99 
1.02 
-
1.02 
3.41 
3.07 
-
— 
(39-
6.06 
7.30 
1
 8.07 
3.07 
5.17 
4.77 
— 
1.72 
4.79 
4.01 
3.73 
1.ΘΘ 
5.73 
12.46 
-
0.93 
•104) 
b 
5.99 
7.08 
8.04 
3.00 
5.08 
4.74 
-
1.44 
5.10 
4.11 
1.97 
7.63 
11.49 
-
0.96 
(60-
3.05 
3.99 
7.26 
1.95 
2.04 
3.08 
-
1.76 
3.65 
4.02 
2.74 
0.90 
2.78 
9.09 
-
1.01 
•104) 
b 
3.26 
3.95 
7.03 
1.91 
2.12 
3.13 
-
1.78 
3.50 
3.96 
-
1.03 
3.34 
7.83 
-
D.97 
(66-
3.05 
2.88 
5.18 
1.92 
2.04 
3.27 
-
0.77 
3.86 
3.13 
2.70 
0.97 
3.45 
7.81 
-
1.12 
• 104) 
b 
2.95 
2.83 
4.12 
1.98 
2.01 
3.17 
-
0.73 
3.73 
3.08 
-
0.95 
2.32 
7.68 
-
1.06 
(39-
2.93 
3.83 
1.06 
1.12 
3.06 
2.01 
-
-
0.96 
-
0.9B 
1.00 
3.49 
2.92 
-
— 
• 59) 
b 
2.ΒΘ 
3.62 
1.07 
1.03 
3.04 
2.10 
-
-
0.92 
-
-
0.99 
3.65 
2.03 
-
— 
СП 
СП 
a Theoretical values correspond to the nearest integer; no corrections шеге made for loss 
on hydrolysis; Trp and Cys шеге not determined; - refers to an amino acid, which ujas 
expected not to be present; side chain amino groups of the fragments are protected 
ujith the Msc-function. 
b After dinitrophenylation. 
с Fraction 1. from fig.II.3.4.b. 
d Fraction 2. from fig.II.3.4.b. 
e 1 homoserine included. 
f Methionine-sulfoxide included, 
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C H A P T E R III 
A BIOLOGICALLY ACTIVE COMPLEX FROM TWO COMPLEMENTARY 
FRAGMENTS OF CYTOCHROME С 
111.1. INTRODUCTION 
The chelation of protein fragments, leading to a mole 
cular complex which has a similar tertiary structure as the 
corresponding, intact protein, uas pointed out in section 
1.3.2. as an important factor in the semisynthesis of that 
protein from such fragments. 
In section 1.4.1. several examples haue been giwen of 
such noncovalent complexes, uhich behaue biologically as 
шеіі functioning compounds and haue apparently a quasi 
natural structure. Table 1.4.2. shous that some of them со 
cern cytochrome c. 
Since this inuestigation intended the semisynthesis 
of cytochrome с analogues from a natural and a specifical­
ly modified, complementary fragment of the protein, a firs 
study uias deuoted to the formation of a molecular complex 
from the natural tryptic fragments, representing the se­
quences (1-38) and (39-104). The results of this study, 
the formation and isolation of such a complex and its phy-
sicochemical and biological properties, compared iiiith those 
of cytochrome c, are described in this chapter. 
III.2. EXPERIMENTAL 
111.2.1. Materials. 
The partially protected fragments corresponding to the 
sequences (1-38) and (ЗЭ-10А) of horse heart cytochrome с 
(Sigma chemical со., type Ml) were isolated and purified 
as described in chapter II, 
Beef heart cytochrome с oxidase, purified as described 
by van Buuren (1), and a succinate cytochrome с reductase 
preparation, isolated as described by Yu (2), were gifts 
of Dr. B.F. u. Gelder (В.С.P. Jansen Institute, University 
of Amsterdam, The Netherlands). Sephadex gels шеге from 
Pharmacia Fine Chemicals and carboxymethyl-cellulose ion 
exchanger (СП-52) шеге from Uhatmann Biochemicals. 
111.2.2. General procedures. 
Column eluates шеге monitored ujith a LKB Uvicord type 
III instrument. U.U., vis.-spectroscopic measurements шеге 
performed uiith а Сагу 11Θ instrument. Amino acid composi­
tions шеге determined uiith a modified Jeol JLC-GAH analy­
zer after hydrolysis in 5.7 N hydrochloric acid (Merck, 
suprapur) at 110 -1150C for 2Д h. in sealed evacuated tubes. 
111.2.3. Deprotection of the partially protected tryptic 
fragments of cytochrome с and purification of the 
peptides. 
Remoual of the Msc-group from the N -protected frag­
ments uias performed by the injection of 1 l\l NaOH (0.25 ml) 
into a solution of 20 mg of the compound in 1 ml of a 3:1 
(υ/υ) mixture of dimethylsulfoxide and methanol uith vigo-
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rous stirring. The resulting, initial base concentration 
ыаз 0.2 N. Exactly 3G seconds after the injection the so­
lution was acidified with 5% (v/v) aqueous acetic acid, and 
the deprotected peptide was purified by gelfiltration through 
Sephadex G25-fine (column dimensions 2 χ 35cm) using 6% 
(ν/υ) aqueous acetic acid as the eluent. 
The deprotected peptides were recovered by lyophiliza-
tion. Further purification uas achieved by ion exchange 
chromatography on carboxymethyl cellulose (Cffl-SZ column 
dimensions 0.6 χ 16 cm) with a linear gradient, consisting 
of 100 ml of 0.02 M and 100 ml of 0.20 M phosphate buffer 
pH 6.9. The flow rate was 25 ml/h. Since the solubility of 
the peptide (39-104) at neutral pH is much less than that 
of the heme containing peptide (1-38), the buffers used for 
the chromatography of the former were made up AM in urea. 
The fractions containing the purified fragments were de­
salted and freed from urea by passage through Sephadex 
G25-fine (column dimensions 4 χ 40 cm) using 6% aqueous 
acetic acid as the eluent. The compounds were recovered by 
lyophilization. 
III.2.4. Formation and isolation of a noncovalent complex. 
A noncovalent peptide complex was prepared by mixing 
equimolar amounts of the ferri-heme peptide and the non-
heme peptide in 0.01 M IMaCl. 
Idhen a molar excess of one of the peptides was used, 
the remaining peptide could be removed by chromatography 
on Sephadex G50-fine (2 χ 135 cm) equilibrated with 0.05 fi 
phosphate buffer pH 6.9. The column was eluted with the 
same buffer at a flow rate of 25 ml/h. The solution con­
taining the complex was either lyophilized or concentrated 
by passage through a small CM-cellulose column (0.5 χ 3 cm), 
In the latter case the absorbed complex was eluted with 
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15 ΡΊ phosphate buffer pH 6.9 as a concentrated solution 
ich mas rapidly frozen and then stored at -20 C. 
1.2.5. Physicochemical inuestigations of the complex. 
The chromatographic behav/iour of the reconstituted com­
plex was compared to that of native cytochrome с on an 
ion exchange column, by passage of both compounds through 
a column of carboxymethylcellulose (0.6 χ 16 cm) in 0.1 
Π phosphate buffer, pH 6.9 at the same flou rate (12 ml/h), 
Fractions of 3 ml шеге collected. 
Solutions for a spectral titration of complementary com­
ponents were prepared by mixing increasing amounts of 
a concentrated aqueous solution of the non-heme peptide 
with a fixed amount of a solution of the heme peptide. 
The resulting mixtures шеге adjusted to the same volume 
and the spectrum, belonging to the oxidized form was 
recorded. The spectrum of the reduced form was recorded 
after the addition of a minute amount of solid sodium 
dithionite to the mixtures. In the reduced system the in­
crease of the absorbance at 550 nm. шаз measured as a 
function of the ratio between the amounts of non-heme 
and heme peptide. All measurements uere performed with 
solutions 0.01 molar in NaCl. 
The reduction of the isolated complex with L-ascorbic 
acid was studied spectrophotometrically at a constant 
wavelength of 550 nm. The reduction was started by injec­
tion of 100 μΐ of a 60 mP\ aqueous solution of ascorbic 
acid, which was previously adjusted to pH 5 by the addi­
tion of solid tris base, into 2.5 ml of a 2.5 μ M solu­
tion of the complex in 0.01 ΓΊ NaCl. 
The temperature dependence of the absorption band at 
695 nm. was measured in a jacketed cuvette, connected 
with a thermostate and equipped with a thermistor. The 
temperature of the cuuette uas continuously raised or 
lowered with a rate of D.8 C/min. or D.4 C/min,f res-
pectiuely. Absorption values (registrated 32 times/min. 
with an accuracy of 10 )and temperature values (read 
-3° 2 times/min, with an accuracy of 10 С) шеге collected, 
and averaged uiith the aid of an alphtronic OS 300 mini­
computer (Diehl). 
The stability of the protein structure of the noncova-
lent complex towards chemical modification was examined 
by recording the disappearance of the absorption maxi­
mum at 695 nm. after treatment of an aqueous solution 
of the noncovalent complex with a water soluble carbo-
diimide. 
The pH of a solution of 0.65 yMoles of the noncovalent 
complex in 0.01 M NaCl was adjusted to 4.75 by the addi­
tion of 0.1 N HCl. 33 yMoles of solid 1-ethyl-3-(3-dime-
thylaminopropyl)-carbodiimide hydrochloride were added 
with stirring and the pH was kept constant at 4.75 by 
the addition of 0.1 N HCl. The absorption maximum at 
695 nm. was recorded at regular intervals (ca. 5 min.) 
during one hour. The procedure was repeated with cyto­
chrome c, and the results were compared. 
1 
H NMR spectra were determined using a Bruker 360 MHz 
spectrometer, operating in the Fourier transform mode. 
Chemical shifts are quoted in PPm. downfield from the 
methyl resonance of 2,2-dimethyl-2-silapentane-5-sul-
phonate. NH protons were exchanged by equilibration of 
2 
the samples with H_0 buffered with sodium phosphate 
pH 6.9 (0.1 M), at 40oC for 30 min., followed by lyophi-
lization. The lyophilized samples were dissolved in 
2 
H2O. After addition of a minute amount of sodium dithio 
nite, the spectra were recorded at 55 C. 
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III.2.6. Determination of biological actiwities. 
The oxidation of the reduced complex u/ith cytochrome 
c-oxidase bias investigated using the ascorbate-tetramethyl-
phenylene-diamine system (3f 4). The rate of oxygen uptake 
bias measured polarographically uiith a Clark oxygen elec­
trode mounted in a thermostated (25 C) reaction vessel. 
The reaction mixture contained 0.05 \imol/l of cytochrome-
aa-7 in a phosphate buffer (50 mmol/1, pH 6.θ). It ыаз made 
up 1.0 mmol/1 in tetramethylphenylene-diamine (TMPD), 60 
mmol/1 in ascorbate, 250 mmol/1 in sucrose and contained 
tujeen-80 to give a concentration of 0.5%. 
The reductase activity шаз measured spectrophotome-
trically by recording the change in absorbance at 415 nm 
(the Soret region). The reaction mixture contained 7.5 pg 
of the reductase in 1 ml of an aqueous solution which шаз 
made up 50 mmol/1 in tris/HCl pH B.0, 250 mmol/1 in sucro­
se and 10 mmol/1 in succinate. 
Concentrations of cytochrome с or the complex ranged 
from 0.2 - 1.2 ymol/l for measurements of the oxidase ac­
tivity and from 1 - 4 pmol/l for measurements of the reduc­
tase activity. 
III.3. RESULTS MD DISCUSSION 
Both the heme and the поп-heme peptide could be easily 
deprotected by the very short (30 sec.) treatment with al­
kali as шаз previously described for native cytochrome с 
(5). 
The deprotected peptides appeared to be almost homo­
geneous upon chromatography on carboxy-methylcellulose 
(Fig. II.3.1.) and exhibited the expected composition on 
amino acid analysis (table III.3.1,). 
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Fig. 111.3,1. Chromatographic purification of 
a. fragment (39-104), and b. fragment (1-З ) on 
CM-52 cellulose. 
The heme containing cytochrome c-(1-38)-octatriacontapep-
tide was obtained in 91% yield; the yield of the colour­
less cytochrome c-(39-104)-hexahexacontapeptide fell off 
during purification and amounted to Б2%. 
The absorption spectra betiueen 25D and 730 nm. of a 
solution of the heme peptide in the oxidized and in the 
reduced form are shoun in Fig. III.3.2.A. The reduced form 
turned into the oxidized form on exposure of the solution 
to air. 
Additions of the non-heme peptide changed the spectrum 
of the oxidized form and gave ultimately a spectral curue 
(Fig. III.3.2.B.), identical to that of oxidized cytochrome 
c. The spectrum exhibited a full developed 695 nm. absorp­
tion band. This band is a sensitive characteristic for the 
ligation of the heme-iron atom with the sulfur atom of 
methionine-B0f as occurs in cytochrome с (6). 
Stepwise addition of small amounts of the non-heme 
peptide to a fixed amount of the heme peptide gradually 
increased the absorption at 550 nm. of the reduced form 
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Wavelength (nm) 
Fig. III.3.2.A. Spectra of solutions of the oxidized 
(full line) and reduced (broken line) forms of the heme 
peptide (1-38); cone.: 1.2ХІ0- mol/1; solwent; phos­
phate buffer 0.1 mol/lf pH B.9; centre panel: read or­
dinate χ 4. Inset, continuation of the spectrum of the 
oxidized form; cone.: 15.6x10- mol/1 in the same solvent, 
B. spectra of the stoicheiometric complex. Conditions 
as specified in A. 
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until the value A550 = 0.92 had been reached (measurements 
1, 2, 3f 4 and 5; Fig. 111,3.3.); further additions did not 
cause any enlargement of the absorption (measurements 6, 
7 and B). The equimolar mixture of the two fragments in the 
reduced form appeared to be stable on exposure to air. 
Fig, III.3.3. Changes in th 
absorption at 550 nm. and 5 
nm. of the ferro-heme pepti 
(1-38), following the addi 
tion of increasing amounts 
of the non-heme peptide 
(39-104). Final concentra­
tion of the ferro-heme pep­
tide 42 цтоі/1. 
500 
WavetengtMnm) 
Fig. III.3.4. shows a plot of the absorption change at 
550 nm. against the molar ratio of the non-heme and heme 
peptides. It appears that no further absorption change 
occurs when the molar ratio has reached unity. Apparently 
the complementary fragments form a stoicheiometric complex. 
6 
ΔΑ 550nm. 
Fig. III.3.4. Plot of the 
absorption change at 550 nm. 
against the molar ratio of the 
non-heme and heme peptides. 
(39-104) (i-: 
An increase in the absorption of the α, В or Soret 
peaks шаз not observed, when the heme peptide uas reduced 
with dithionite prior to the addition of the non-heme pep­
tide. Îdhen an excess of dithionite was used the absorption 
maximum of the Soret peak шаз even drastically lowered. 
Presumably, dithionite exerts a destructive effect on the 
prosthetic group which is fully exposed in the heme frag­
ment. Complex formation with the complementary fragment 
causes a high degree of masking of the prosthetic group 
which might effect protection against the detrimental action 
of dithionite. 
Another indication of the formation of a complex, com­
parable to the intact cytochrome с is obtained when the non-
heme peptide was subjected to chromatography on cellulose 
acetate sheets (7) in a neutral aqueous medium. Because 
of its poor solubility at neutral pH the non-heme peptide 
does not migrate under the conditions. However, after addi­
tion of an equivalent amount of the heme peptide, both 
fragments migrated as a single entity and travelled over 
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the same distance as native cytochrome c. 
The noncoualent complex could be isolated from a re­
action mixture containing an excess of one of the tuo pep­
tides by gelfiltration using conditions, preventing denatu-
ration (Fig. III.3.5). 
Fig. III.3.5. Isolation of 
the stoicheiometric complex 
(1.) from a mixture, contai­
ning an excess of fragment 
(1-3Θ) (2.) by gelfiltration. 
EMon vcAjnebrt.) 
Upon rechromatography of the isolated complex under the 
same conditions, the complex tuas eluted as a single symme­
trical peak; a non-coloured and a coloured peak appeared 
on rechromatography under denaturating conditions, viz. 
in Ί% (ν/υ) aqueous formic acid. 
The complex behaved exactly like native cytochrome с 
during ion exchange chromatography on carboxymethylcellu-
lose (Fig. III.3.B.). The amino acid analysis of the isola­
ted complex proved to be identical uiith that expected for 
native cytochrome с (table III.3.1.). 
The 695 nm. absorption band of the isolated complex 
disappeared after removal of salts from its solution. Upon 
addition of phosphate or sodium chloride to a solution of 
the noncovalent complex in distilled water, which does not 
contain an absorption maximum at 695 nm, the absorption band 
1.0 
2e0nm 
0.5 
Л' 
]\f\ 
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at 695 nm. reappeared, pointing to restoration of the normal 
iron-sulfur ligation. Obuiously, salts haue a stabilizing ef­
fect on the conformation of the complex. The same phenome­
non has been reported for maleylated cytochrome с (В). 
280nm 
Fig. III.3.6. Chromatographic 
behaviour of the reconstitu­
ted complex (b.) as compared 
to horse heart cytochrome с 
(a.) on carboxymethylcellu-
lose. 
10 
Fraction number 
A study of the temperature dependence of the 695 nm. 
band of the complex, dissolved in 0.01 molar sodium chlo­
ride solution, shoided that it is slightly less thermosta­
ble than cytochrome c; the progress of the denaturation 
of the complex in the range between 25° and 65α0 equals that 
of cytochrome с at temperatures which are continuously 5 С 
higher (Fig. III.3.7.). At 650С the maximum at 695 nm. has 
completely disappeared, but the absorption was restored to 
its normal value on cooling. Apparently the thermal dena­
turation of the complex is completely reversible as it is 
for cytochrome c. 
Reaction of the noncovalent complex with a water-
soluble carbodiimide at pH 4.75 resulted in a gradual dis­
appearance of the absorption maximum at 695 nm. which is 
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Fig. III.3.7. Changes in 695 nm, 
absorption with temperature of 
cytochrome с (closed circles) 
and of the noncovalent complex 
(open circles); measurements 
are performed with solutions 
D.137 mmolair (D.QIM in NaCl). 
completed after 20 minutes; in a similar treatment of cyto­
chrome с the absorption maximum at 695 nm. remained unchanged. 
Permanent abolishment of the 695 nm. band of cytochrome с 
occurs here only when the protein, after reaction uith the 
carbodiimide, is denaturated with formic acid and the acid 
is subsequently removed by gelfiltration after preceding 
treatment with urea. 
It has been reported that a uater-soluble carbodiimide 
causes disappearance of the 695 nm. band of cytochrome с 
when the enzyme is treated with the reagent at the lower 
pH of 3,7. This should result in the formation of a cyto­
chrome с deriuatiue, originating from the specific con­
version of the carboxyl group of the propionic acid side 
chain at the exposed pyrrole ring 3 and the carboxyl group 
of the aspartic acid residue at position 62 into acylurea 
groups (9, 10). The lower pH value of 3.7 probably causes 
a partial denaturation of the protein which might be the 
reason for the absence of the 695 nm. band immediately after 
the modification reaction. The higher thermolability and the 
more easy disappearance (viz, at higher pH) of the 695 nm. 
band in the presence of a carbodiimide suggest a looser 
conformation for the complex in comparison with native cyto­
chrome c, 
69 
An explanation of this difference betujeen the confor­
mation of the noncovalent complex and of native cytochrome 
с might be offered in a consideration of the tertiary struc­
ture of cytochrome cf in uhich the lower part of the mole-
culet containing the sequence (39-58) is present as a pe­
ripheral loop. Cleavage of one peptide bond within or in 
the nearest neighbourhood of this part of the amino acid 
sequence will then provide complementary fragments which on 
mixing may yield a molecular complex, having approximately 
a similar tertiary structure as cytochrome c. However the 
peripheral loop (ЗЭ-5В) may attain another, less defined or 
more loose structure. This peripheral loop does not seem to 
be very essential for the biological function in intact 
cytochrome с since it is deleted in cytochrome c-551 from 
Pseudomonas aeruginosa (11, 12). 
Loosening of the conformation of the complex in the 
region which corresponds to the sequence (39-5B) might also 
be the reason for the diminished activity of the complex 
towards ascorbate reduction. It is suggested that ascorbate 
reduction of cytochrome с involves a mechanism in which 
ascorbate binds at or close to arginine-38 and that elec­
trons then migrate from that point to the heme-iron through 
a series of hydrogen bondings (13). Upon reduction of the 
complex with ascorbic acid the intensity of the absorption 
band at 55G nm. is only 19% of that, found after reduction 
of the complex with dithionite. 
NMR-spectroscopy is now the most promising technique 
for getting insight in conformational details of cytochrome 
с in solution (14). Therefore, the MMR spectrum of the com­
plex (1-38):(39-1Oü) was measured in order to compare it 
with that of cytochrome c. 
In Fig. III.3.8. the high-field (A) and aromatic (B) 
regions of the noncovalent ferro complex and ferro-cyto-
chrome c, measured at 360 ΠΗζ, have been reproduced. Since 
the direct assignment of individual signals, especially in 
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the aromatic region, could not yet be performed, the analy­
sis of the spectra, giuen here, has a preliminary character 
and has to be restricted to the uell-resolued regions at the 
high- and loui-field sides. Ноше ег, euen from a qualitative 
comparison it seems quite clear, that the characteristic 
CH,-S-resonance of methionine-80 (M.. in cytochrome с at 
6-3.28) and also the other proton resonances of this amino 
acid residue ( in cytochrome c: -0.19, C_; -1.87, C,; -2.58, 
C_; -3.73, C-,) are present in the spectrum of the complex 
at the same or nearly the same positions. The iron-ligation 
with methionine-8Q is certainly preserved in the reduced 
complex. The presence of histidine-1B as the other axial 
iron-ligand in the complex is also unquestionable, since 
the signals of the ring protons of this residue at δ 0.13 
(A33, HC,) and 0.50 (A32, HC-) in cytochrome с occur at 
equally high-field in the complex. 
Another characteristic signal in the high-field re­
gion of the spectrum of cytochrome с is that of the δ-CH, 
protons of isoleucine-57 (M. at δ -0.45); its high-field 
position is due to a shielding effect of tyrosine-74. In the 
spectrum of the complex the signal does not occur in this 
region, in accordance uith the supposition that the confor­
mation of the region at the Іошег-left side of the heme 
group (see Fig. I.2.2.2.), partly corresponding to the se­
quence (39-58) might be disturbed. On the other hand, the 
signals of the methyl protons of leucine-32, outside this 
region (δ -0.60, M, and -0,76, M- in cytochrome c), are 
unchanged in the spectrum of the complex, indicating that 
this residue has remained in close proximity to the porphy­
rin ring and that the region at the right side of the pros­
thetic groups is probably unperturbed. 
In the Іош-field part of the spectrum of the complex 
the resonances of the four methine protons of the porphy­
rin ring are present in the region 9-10 ppm, but the chemi­
cal shift values, at least of some of them, are significantly 
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Fig. ІІІ.З. . Дгота іс (A) and high-field (В) regions 
of 360 WHz NMR spectra of native cytochrome с (upper 
trace) and of the noncovalent complex (louer trace). 
Signal at 8.43 ppm is due to residual formic acid. 
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different from those of cytochrome с itself. This observa­
tion is in agreement üjith the supposition that the align-
ment of the protein envelope around the heme group is not 
completely similar in the complex as in the protein, but it 
deserves a more thorough analysis of these spectral diffe-
rences to define more detailed conclusions concerning con-
formational differences from this part of the spectrum. 
For that purpose a precise analysis of the more complex 
part of the aromatic region of the spectrum should also be 
necessary. Native cytochrome с reacts uith cytochrome c-
oxidase exhibiting biphasic kinetics. The app. Km values 
of the tuo phases correlate uith the Kd values of tuo mo­
lecules of cytochrome с on the oxidase (3, 4). Weasurement 
of the electron transfer activity of the noncovalent complex 
touards the cytochrome c-oxidase system iiias carried out uith 
substrate concentrations, varying from 0.2-1.2 ymol/1. In 
the Ιοω concentration range, only the interaction betueen 
the high affinity binding site of the oxidase and the sub­
strate is studied. 
Fig. III.3.9. shoijs a double reciprocal plot, according 
to Lineuieaver and Burk, of the oxidation rate and the sub­
strate concentration. It appears that the process of oxida­
tion indeed gives rise to monophasic kinetics, over the 
whole substrate concentration range studied. It can be con­
cluded that the splitting of the -Дгд -Lys -peptide bond 
in cytochrome с changes the oxidase activity profoundly. 
The Km-value of the complex is two-fold increased compared 
with cytochrome c, indicating a diminished affinity of the 
complex to the oxidase. The electron transfer activity of 
the complex is found to be considerably faster then that of 
cytochrome c, which can be deduced from a 2.5-fold increase 
of Umax. It is noteworthy to emphasize that the complex, 
notwithstanding its more open or looser conformation, is not 
autooxidizable under the conditions used for the activity 
determinations, and that the rate of oxygen uptake is not 
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influenced by the addition of an excessive amount of one of 
the fragments (1-3B) or (39-104). 
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Fig. III.3.9. ІЛпешеа ег-Вигк plots (I.) of the 
oxidase activities of cytochrome с (A) and of the 
noncoualent complex (В); и is expressed in micromoles 
of oxygen consumed/sec, с is expressed in micromoles/l, 
II. changes in absorption at 415 nm. uihen 3.2 ymol/1 
solutions of the complex (A) and of native cytochrome 
с (В) are reduced by a succinate-cytochrome c-reduc-
tase preparation. 
The reaction of the complex uith cytochrome c-reducta-
se follows a course, completely different from that of na­
tive cytochrome с (Fig. III.3.9.II). It is кпошп that the 
reduction depends on some rate-limiting process within the 
complicated reductase system (15). In the concentration 
range 1-4 ymol/l. zero order kinetics are found for native 
cytochrome c; rate vs. concentration curves coincide comple­
tely under varying starting conditions. The rate of the re­
constituted complex, however, shows a concentration depen­
dency; the change of absorption at 415 nm. does not reach 
the same value as is achieved with an equal concentration 
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of natiue cytochrome с. The modest owerall activity of the 
complex, prepared by mixing the two acetimidylated fragments 
(1-38) and (39-104), as measured in the depleted mitochon­
drial system (16), might well find its cause in this hampered 
reaction uith the reductase. 
Table III.3.1. Amino acid composition of the heme 
peptide (1-38) (l), the non-heme peptide (39-1G4) 
(II) from cytochrome c, and of the noncovalent com­
plex (ill), formed from equimolar amounts of I and II . 
Residue 
Asp 
Thr 
Glu 
Pro 
Gly 
Ala 
Val 
Het 
Ile 
Leu 
Туг 
Phe 
NH, 
Lys"3 
His 
Arg 
I 
2.00(2) 
1.74(2) 
4.14(4) 
1.04(1) 
7.03(7) 
1.11(1) 
2.73(3) 
— 
1.04(1) 
1.95(2) 
1.BB(2) 
3.62 
6.86(7) 
2.67(3) 
0.72(1) 
II 
6.11(6) 
7.13(7) 
B,38(B) 
3.07 З) 
5.05(5) 
4.77(5) 
— 
1.66(2) 
4.74(5) 
3.95(4 
3.69(4 
1.92(2) 
5.93 
11.99(12) 
— 
0.B7(1) 
III 
7.93(8) 
8.64(10) 
12.21(12) 
4.14(4) 
12.29(12) 
6.37(6) 
2.90(3) 
1.75(2) 
5.85(6) 
6.27(б) 
3.58(4) 
3.79(4) 
9.34 
18.64(19) 
2.63(3) 
1.75(2) 
No corrections шеге made for loss on hydrolysis; Cys 
and Trp were not determined; — refers to a residue 
which uias expected not to be present; literature values 
in parentheses. 
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C H A P T E R IV 
A MODEL STUDY FOR THE POSSIBLE ENZYMATIC RECOMBINATION OF 
TWO COMPLEMENTARY FRAGMENTS OF CYTOCHROME С 
IV.1. INTRODUCTION 
In the semisynthesis of proteins or polypeptides the 
final couplings between large peptide fragments are gene­
rally the crucial steps. Most of the available methods for 
the selectiue cleavage of proteins are sufficiently develo­
ped to obtain pure fragments in good yields (see Chapter II). 
Their recombination encounters still several difficulties, 
homever, because most methods for the formation of peptide 
bonds require protection of all side chain carboxyl and 
amino groups. 
The formation of a molecular complex of native struc­
ture betujeen the fragments, to be coupled, may be helpful 
in the performance of an intended condensation reaction. 
In the previous chapter, the formation of such a noncova-
lent complex from tuo tryptic fragments of horse heart cyto­
chrome c, which resembles in many aspects the uncleaved pro­
tein, has been described. Ноше ег, such a complex is only 
formed u/hen the tuo fragments are unprotected. The protec­
tion of the side chain amino functions of one or both frag­
ments uiith Msc-groups prevents the complexation, as appeared 
from the absence of an increase in the α f ß or Y bands of 
the heme-containing fragment and the absence of a 695 nm 
absorption band upon spectral titration with the comple-
mentary sequence (see Chapter III). 
Treatment of the unprotected complex (1-38):(39-104) 
with a water soluble carbodiimide, as described in Chapter 
III, resulted in covalent coupling, but restoration of the 
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38 39 Arg -Lys peptide bond was certainly not the only effect. 
Possibly, other reactiue groups шеге inwolved in cross­
links between the components. Moreover, it is knoum, that 
treatment of cytochrome с (or a corresponding noncoualent 
complex) with a carbodiimide causes transformation of some 
side chain carboxyl groups into acylurea residues (see 
Chapter III). 
An attempt to protect specifically the side chain car-
boxylic acid function in the fragment (1-38) by complete 
esterification and subsequent liberation of the a-carboxylic 
acid function of residue-38 by the esterase action of tryp­
sin, failed because only 50^ of the acidic functions appea­
red to be esterified after reaction of the fragment (і-ЗВ) 
with r0eOH/BF3 or MeOH/HCl. 
Even, when complete protection of all acidic side chain 
functions could be realised, another problem should arise 
because of the presence of protected aspartic acid residues 
in the polypeptide. Treatment with a base, e.g. for the re­
moval of amino- or carboxyl- protecting groups should cause 
rearrangement of these ß-protected aspartic acid residues, 
leading to a mixture of a- and ß-aspartyl peptides (1, 2). 
From these considerations it is clear that the coupling 
of the two fragments (1-38) and (39-104) using ordinary 
chemical methods involves serious difficulties. Theoreti-
cally, the use of the unprotected fragments is a method to 
get round many of these difficulties; but in general, this 
procedure excludes the selective activation of the a-carbo-
xyl group for the coupling reaction. 
As already mentioned in section 1.3.2. two methods have 
been found, which can in principle solve the problem of se-
lective carboxyl group activation without side chain protec-
tion, viz. the use of a cyanogen bromide fragment in which 
the C-terminus is activated as a homoserine-lactone residue 
and the use of the reverse action of a proteolytic enzyme. 
The latter method goes back to the observations of 
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Bergmann and Fraenkel-Conrat (3) and Bergmann and Fruton 
(4), шЬо showed that papain and chymotrypsin catalyze the 
coupling of acylamino acids and amino acid anilides. During 
the last years a renewed interest in the application of 
proteolytic enzymes to the synthesis of peptide bonds has 
arisen. Tuo different approaches can be distinguished, a 
thermodynamic and a kinetic one. 
The principle feature of the thermodynamic approach 
is the removal of a product from an equilibrium mixture of 
reactants and products, formed by enzymatic action. This 
can be done, e.g. by the introduction of suitable protecting 
groups in the reactants which yield an insoluble product. 
The syntheses of opioid peptides, enkephalins and several 
potent analogues, employing the enzymes papain, chymotryp­
sin or thermolysin as catalysts, are examples of this type 
of enzymatic synthesis (5,6,7). 
The basis of the kinetic approach to enzymatic peptide 
synthesis is the competition between aminolysis e.g. by an 
amino acid amide and hydrolysis by water of the acylenzyme 
complex formed from the carboxyl component and an enzyme. 
The ratio of aminolysis to hydrolysis depends on the concen­
tration of the nucleophile which must compete with 55 M water 
in an aqueous medium. In the chymotrypsin catalyzed hydro­
lysis of l\l-acetyl-(L)-phenylalanine ethyl ester, addition of 
alanine amide in one molar concentration appeared to be 
sufficient to compete efficiently with the hydrolysis, re­
sulting in the predominant formation of an N-acyl dipeptide 
amide (Θ). Oka and Morihara have further exploited this 
principle; they synthesized a number of oligopeptides from 
N-acyl-amino acid esters and amino acid derivatives as nu-
cleophiles, using trypsin and chymotrypsin as a catalytic 
species (9,10). 
The application of the enzymatic peptide bond synthe­
sis to the coupling of large protein fragments was first 
demonstrated in the reformation of an enzymatically hydro-
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lyzed peptide bond in soy-bean trypsin inhibitor (il) and 
in trypsin-kallikrein inhibitor (12) with the same proteo­
lytic enzyme. 
From these studies it appeared that the nature of the 
solwent has a great influence on the relative rates of elea 
uage and reformation of a peptide bond (13). This effect uia 
further inuestigated by Hommandberg et al (14). They used 
the system N-benzyloxycarbonyl-tryptophan and glycine amide 
in the presence of chymotrypsin, and showed that the addi­
tion of large amounts of organic solvents (up to 85^ 5 (v/v)) 
such as glycerol, various diols, acetonitrile etc., signi­
ficantly increased the yields of dipeptide. Shifting of the 
equilibrium is due not so much to the reduction of the ac­
tivity of water, but rather more to the decrease of the dis 
sociation constant of the carboxyl group of the N-protected 
reactant, i.e. the increase of the concentration of the un­
charged species. 
This technique has been employed in the subtilisin ca­
talyzed recombination of RNase-S peptide and S-protein in 
90^ (v/v) glycerol (15). However, the action of subtilisin 
20 21 is not limited to the Ala -Ser peptide bond in that case 
21 22 the Ser -Ser peptide bond is also subjected to proteolys 
and resynthesis, so that the product formed is a mixture of 
ribonuclease Д (1—124); des-Ser -ribonuclease A (1—20-
22—124) and Ser21A-ribonuclease A (1—21-21—124). 
Similar problems were encountered in the trypsin-cata-
lyzed conversion of a molecular complex containing large 
Staphylococcal nuclease-T fragments, into a covalent prod­
uct (16). The product formed from the incubation of the try 
tic fragments (6-48) and (49-149) of nuclease with trypsin 
in 90% (v/v) glycerol, appeared to be the biologically in­
active des-Lys -nuclease-(6-1 49) . The deletion in the pro-
48 duct did not appear when a synthetic Gly -nuclease-(6-49) 
fragment was combined with a native nuclease-(50-149) frag­
ment (17). The product formed from these fragments was the 
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biologically active Gly -nuclease-(6-149). 
The enzyme-assisted peptide synthesis in partly aqueous 
media has also been applied successfully in semisyntheses of 
insulin. Porcine IM0"*1-, Ν α Β 1 - ( Boe) 2-des-( B23-B3Q)-octapep-
tide-insulin and the synthetic Νε -Boc-(B23-B30)-octapep-
tide hawing threonine in position B30 have been linked by 
incubation ujith trypsin in 50% (v/v) dimethylformamide to 
give a final yield of 40% of human insulin (IB). The same 
technique has been used to prepare porcine Leu "insulin 
В 25 
and Leu -insulin (19). Replacement of alanine-ВЗО in por­
cine insulin by threonine could also be achieved by the con-
B 30 
densation of porcine des-Ala -insulin and Thr(0But)f em­
ploying trypsin as the catalyst in 50% (v/v) dimethylforma­
mide (20). It is remarkable that under these condition 
ρ 9 ο η η "7 
splitting of the Arg -Gly peptide bond uas not observed. 
In order to study the usefulness of enzymatic peptide 
bond synthesis in the planned semisynthesis of cytochrome c, 
the trypsin catalysed condensation of the tryptic heme pep­
tide, corresponding to the residues (1-38) of cytochrome с 
ujith a small model peptide Н-0гп(Мзс)-Тгр-1\1НСН3, шаз inves­
tigated. The composition of the model dipeptide uas based 
on the follouing considerations. 
The presence of tryptophan facilitates a qualitative 
detection of the incorporation of the peptide in the heme 
fragment by U.\/. spectroscopy in the 260-320 nm range. The 
heme fragment itself does not contain tryptophan, whereas 
the heme moiety presents a "ujindouj" in the relevant U.U. 
region (see also section III.3.). Ornithine шаз chosen 
as the l\l-terminus because cytochrome с contains the related 
lysine at the corresponding 39-position. In quantitative 
studies of the dipeptide incorporation, by amino acid ana­
lysis, ornithine serves as a diagnostic amino acid, since 
it is uiell separated from lysine, which occurs on seven 
positions of the heme fragment. Finally, the N-methylamide 
group шаз introduced to stabilize the dipeptide against 
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cyclisation under the conditions of the experiment. 
In this chapter the synthesis of the model peptide 
according to scheme IV.1. is described and the results of 
the enzymatic coupling are discussed. 
H-Om-OH 
I 
Z-Trp-OH 
Msc 
H-Om-OH (I) Z-Trp-NHCH, (Ш) 
Msc 
ι 
Z-Om-ONp ( I ) • H-Trp-NHCH3 
Msc I 
г-огп-Тф-мнсНз(і ) 
Msc I 
H-Orn-Trp-NHCHj (V) 
Scheme IV.1. Synthesis of 
the model peptide-amide. 
IV.2. EXPERIMENTAL 
IV.2.1. Materials and general procedures, 
The partially protected fragment corresponding to the 
sequence (1-38) of horse heart cytochrome с (type VI, Sigma 
Chemical Co.) uas obtained and purified as described in Chap­
ter II and deprotected as described in Chapter III. 
Trypsin mas obtained from Boehringer Mannheim. Sepha-
dex gels шеге from Pharmacia Fine Chemicals and DE-cellulose 
(DE-52) was from Whatmann Biochemicals. 
Thin layer chromatography шаз performed on precoated 
fluorescent silica plates (Merck F254). To develop the chro-
matograms, the folloiuing solvent systems were used: 
A. chloroform-methanol-acetic acid (95:20:3) 
B. 1-butanol-acetic acid-mater (4:1:1) 
B2 
The compounds швге detected by fluorescence quenching or by 
spraying the plates uith ninhydrin, T.D.M. solution or the 
reagent of Ehrlich. 
Specific rotations uere measured with a Perkin-Elmer 
241 Polarimeter, Spectroscopic measurements шеге performed 
with а Сагу 118 instrument. Column eluates шеге monitored 
with a LKB Uuicord type S instrument and amino acid compo­
sitions шеге determined luith a modified Jeol JLC-GAH analy­
zer after hydrolysis of the samples in 5.7 l\l hydrochloric 
acid (Merck suprapur) at 110o-115oC for 24 hrs in sealed 
evacuated tubes. 
IM,2.2. Synthesis of the protected model dipeptide. 
In a solution of 22.55 g (15D mmoles) of ornithine mono-
hydrochloride in about 700 ml of water, 1Θ.73 g (75 mmoles) 
of copper sulfate шеге dissolued. After the PH had been 
adjusted to 10 by addition of 4 N NaOH, 33.Б g (180 mmoles) 
of methylsulfonylethyloxycarbonylchloride, dissolved in 
100 ml of dry tetrahydrofuran, шеге added. During this pro­
cedure the PH tuas maintained at 10 using 4 N NaOH. The pre-
dipitate шаз filtered washed with water, and dissolved in 
'\0% (v/v) acetic acid. A current of H-S was then passed 
through this solution. After ca 2 hrs the suspension was 
filtered. The filtrate was evaporated to dryness, redissol-
ved in water and evaporated again. The product was crystalli­
zed from ethanol/water (1:1). 
Yield 34.2 g (BOjS); Rf=0.16 (B); m.p. = 1970-1980C; 
[α]20
=+
2.0ο, (c=1, H 20); CgH^N^gS: 
caled. С, 38.29$; Η, 6.43$; Ν, 9.92$ 
found С, 38.3 %; Η, 6.4 %; Ν, 9.9 % 
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To a solution of 15 g (49.7 mmoles) of I in IDO ml of 
saturated sodium hydrogen carbonate and 100 ml of dimetnyl-
formamide, 1Λ,5 g (55 mmoles) of benzyl succinimidocarbonate 
dissolued in 100 ml of dimethyIformamide, were added. During 
the addition the pH ujas kept constant at ca 7.5. The reac­
tion mixture mas euaporated and the residue dissolwed in 
ujater and acidified with 3 N hydrochloric acid to PH 1.5. 
The acidic mixture шаз extracted several times with ethyl 
acetate. The combined organic layers шеге washed uith water 
and dried with sodium sulfate. After euaporation, an oil 
was obtained which refused to crystallize. The oil (19.4 g, 
48.4 mmoles) was dissolued in ethyl acetate and cooled to 
0 C. 7.65 g (55 mmoles) of p-nitrophenol and 0.97 g (4B.4 
mmoles) of dicyclohexylcarbodiimide were then added. The 
mixture was stirred for 1 hr at 0 С and kept at room tempe­
rature for 16 hrs. The precipitated dicyclohexylurea was 
filtered and washed with ethyl acetate. The combined ethyl 
acetate layers were dried with sodium sulfate and evapo­
rated to dryness. After treating the residue with ether the 
compound solidified. The product was crystallized from 
2-propanol. Yield 17.9 g (69$); RF=D.75 (A), Rf=0.75 (B); 
m.p.=1270C; [α]ψ--]5.30, (c=1, dioxane); C23H27N3G1DS : 
caled. С, 51.39$; H, 5.00$; l\lf 7.B2$ 
found С, 51.4 %; H, 5.1 %; Ν, 7.θ % 
Z-(L)-Trp-l\IHDH3 (III) 
Θ45 mg (2.5 mmoles) of benzyloxycarbonyl-(L)-tryp-
tophan (21) were dissolved in 25 ml of tetrahydrofuran, and 
the solution was cooled to -15 C. An equimolar amount of 
triethylamine was added, followed by D.335 ml (2.5 mmoles) 
of isobutyl chloroformate. A current of methylamine was then 
bubbled through the solution and after ca 0.5 hr the tempe­
rature was allowed to rise to room temperature. The solution 
was concentrated in vacuo, the residue treated with ethyl 
acetate, and the product crystallized from ethanol. 
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Y i e l d 650 mg ( 7 3 % ) ; Ρ
ρ
= 0 . 7 5 ( Α ) , Я
р
= 0 . 2 ( В ) ; m . р . = 1 7 4 ° -
1 7 5 0 C ; H p D = - 2 . 7 0 , ( c = 1 , MeGH); С 2 0 Н 2 1 М з 0 з : 
c a l e d . С, 6 8 . 3 6 % ; H, 6.02%; IM, 1 1 . 9 5 % 
f o u n d С, 6 8 , 2 %; H, 6 . 1 %; Ν, 1 1 . 9 % 
Z - ( L ) - 0 r n ( | Y l s c ) - ( L ) - T r p - N H C H 3 ( l U ) 
1.02 g (2.85 mmoles) of III шеге suspended in methanol 
and hydrogenated in the presence of palladium on charcoal 
and one equivalent of concentrated aqueous HCl. During the 
uptake of hydrogen the amide ujent into solution, after which 
pyridine (1 equiu.) uas added and the solution filtered. 
The filtrate uas evaporated to dryness and dissolued together 
with 1.54 g (2.85 mmoles) of II in ca 50 ml. of ethyl acetate. 
The reaction uias started by addition of an equivalent amount 
(9.4 ml) of triethylamine. The mixture uas stirred overnight 
and then extracted with water, potassium hydrogen sulfate and 
potassium hydrogen carbonate solutions. The ethyl acetate 
layer was dried on sodium sulfate and evaporated in vacuo 
to dryness. The product was crystallized from acetonitrile. 
Yield 1.54 g (87.7%); Р
р
=0.59 (A), RF=0.68 (В); m.p.= 185°-
1B70C; [а]ц0=-2.8о. (0=1, DMF); C2gH37í\l50aS : 
caled. С, 56.57%, H, 6.06%, Ν, 11.38% 
found С, 56.5 %, Η, 6.1 %, Ν, 11.4 % 
H-(L)-0rn(|visc)-(L)-Trp-NHCH3 (W) 
1 g (1.62 mmoles) of lU шаз suspended in methanol and 
hydrogenated in the presence of palladium on charcoal. The 
peptide went into solution during the uptake of hydrogen, 
The solution was filtered and evaporated to dryness. Д chro-
matographically pure oil was obtained which solidified upon 
drying in vacuo. Yield 0.77 g (99%); RF=0.25 (Д). 
In order to obtain a sample for elemental analysis a 
small amount of V was dissolved in ethanol and converted 
into the monohydrochloride by addition of hydrochloric 
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acid in ethyl acetate. The crystals шеге filtered, mashed 
JD uith ether and dried in vacuo, [a] =+24.1°, (c=1, MeOH); 
2 1н 3 2м 5о 6зсіЧь 2^ 
C H 2 N5 06 S C 1 ,i H D 
caled. С, 47.86$; H, 6.31$; Ν, 13.29$ 
found С, 47.9 %; Η, 6.4 %; Ν, 13.2 % 
IU.2.3. Enzymatic synthesis. 
The l\l -protected fragment corresponding to the resi­
dues (1-3B) of cytochrome с (22 mg, 3.6 mmoles) шаз tho­
roughly purified by passage through a column of Sephadex 
LH-20 (18x0.9cm), uihich шаз equilibrated and eluted with 
dimethylformamide. All traces of Іош molecular ujeight im­
purities шеге remoued in this uay. The heme containing frac 
tion шаз evaporated in vacuo to dryness and dissolved again 
in 250 yl of dimethylformamide. 
A solution of V (75 mg, 0.16 mmoles) in a mixture of 
350 μΐ of ethyl alcohol and 100 μΐ of dimethylformamide шаз 
then added, and the reaction шаз started by addition of 
trypsin (2mg, 83 mmoles) dissolved in 500 μΐ of tris buffer 
0.5M, PH 6.5. The resulting solution шаз left for 24 hrs 
at 37 С after uhich time 1.2 ml of formic acid шеге added. 
The reaction mixture шаз applied to a column of Sepha-
dex-G50 fine (l3Gx3.5cm) uihich шаз equilibrated and eluted 
uith 50$ (v/v) formic acid (floiu rate 35 ml/h). Fractions 
containing red-coloured heme material шеге pooled, concen­
trated in vacuo, and lyophilized after the addition of ujate 
The lyophilized material шаз dissolved in a phosphate 
buffer (0.005m) containing urea (4(4), pH 6.8, and this so­
lution шаз applied to a column of DE-52 cellulose (17x0.9cm 
using a linear gradient, uihich consisted of 100 ml of the 
0.005 molar buffer and 10Ü ml of a 0.05 molar phosphate buf 
fer, 4M urea, PH 6.8. The flou rate шаз 20 ml/h; fraction 
volumes шеге 5 ml. 
ВБ 
Fractions comprising the individual peaks шеге pooled 
and separately freed from urea and phosphate by passage 
through a column of Sephadex-G25 fine (1.5x26cm), uihich 
was equilibrated and eluted with 0.01ΓΊ ammonium acetate, 
pH 6.5, and then lyophilized. 
IV.3. RESULTS AND DISCUSSION 
The synthesis of the partially protected model-dipep-
tide-amide шаз caried out according to scheme IV.1 (see also 
section V.1.2.1.). The intermediates in this synthesis were 
obtained as homogeneous compounds (T.L.C.) and were charac­
terized by elemental analyses. 
The reaction conditions for the enzymatic coupling of 
this model-peptide uith the N -protected heme peptide, could 
be chosen similar to those used by Morihara et al (20), since 
peptides and protein fragments, protected with Msc-groups are 
шеіі soluble in mixtures of dimethylformamide and water. 
The excess of the dipeptide could uell be separated 
from the heme peptide material (fig. IV.3.1.). 
soo etc 
Elution whme (ml ) 
Fig. IV.3.1. Separation of the enzymatic reaction 
mixture by gel filtration on Sephadex G50 in 50% (u/v) 
formic acid. 
B7 
The first peak represents the coloured heme peptide deriua-
tii/es. It is noteujorthy that degradation of the heme peptide, 
in consequence of the chymotryptic actiuity ujhich is present 
in most trypsin preparations (22) urns not observed, even after 
the relatively long reaction time of 24 hrs. 
As the condensation of the monovalent dipeptide deriva­
tive to the C-terminus of the heme peptide is accompanied by 
loss of a negative charge, separation of coupled product and 
unreacted heme peptide should be possible by ion-exchange 
chromatography. Therefore the red heme peptide material was 
subjected to ion-exchange chromatography on a positively 
charged column. Fig. 3.2. shows that the heme peptide fraction 
consists of tuo шеіі separated peaks (A and B) instead of the 
one found before the enzymatic reaction (see Chapter II, fig. 
II.3.4.a.). 
ctfF 
A280r 
0,1 -
/ 
A. 
. 
Λ 
V ι 
15 25 
fraction ntinber 
Fig. IV.3.2. Separation of the octatriaconta-(B) 
and the tetraconta-(A) peptide derivatives resul­
ting from the enzymatic coupling reaction, by ion 
exchange chromatography on DE-52 cellulose 
Both red coloured peaks шеге investigated by U.M. spectro­
scopy and amino acid analysis, 
В 
Comparison of the U.U. spectra of the eluates uiith that 
of the fragment (1-38) of cytochrome c, reproduced in fig. 
III.3.2., indicates that the spectrum of fraction В is iden­
tical idith the spectrum of the unmodified fragment (1-38) 
and that the spectrum of fraction A contains the uell-knoun 
absorption characteristic, brought about by the presence of 
tryptophan (fig. IU.3.3.). 
0,8 
0,7 
0,6 
A 
0,5 
0,4 
2Θ0 300 320 
wavelength (nm ) 
Fig. І .З.З. Comparison of the U.U. absorption 
spectra of the tetraconta-(A) and octatriaconta 
peptide deriuatiue (B). 
On incubation of the latter fraction luith trypsin (without 
organic solvents) and gel filtration of the reaction mix­
ture, the resulting heme peptide has the same absorption 
spectrum as obtained for B. 
Amino acid analyses of the fractions A and В (table 
IV.3.) showed that the presence of an ornithine residue 
in A is the only difference (tryptophan шаз not determined 
because of destruction during hydrolysis). 
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Table IV/.3. : ftmino a c i d a n a l y s i s o f compounds A and В 
Residue Д 
Ш 
Asp 2.02 2.01 
Thr 1.87 1.90 
Glu 4.24 4.21 f4¡ 
Pro 1.03 1.09 (1 
Gly 6.79 7.00 (7¡ 
Ala 1.10 1.0B M' 
Val 2.93 3.05 (З) 
Ile 0,-94 0.99 (1 
Leu 1.98 2.03 (ζ) 
Phe 1.92 1.97 (2] 
NH3 4.70 4.29 
Orn 0.87 
Lys 6.86 6.89 
His 2.81 2.92 
Arg 0.92 0.95 (1) 
ж No corrections иеге made for loss by hydrolysis; the num­
ber of amino acid residues expected for cytochrome c-
(1-3B)-octa-triacontapeptide is given in parentheses. 
In order to prove that the presence of the model-
dipeptide in fraction A is the result of the specific cata­
lytic action of trypsin, the same procedure uas repeated 
ujith the omission of trypsin. Analysis of this reaction 
mixture by ion exchange chromatography shouied that the heme 
peptide fraction had remained homogeneous. It did not shou 
the typical U.V.-spectrum of a tryptophan containing peptide, 
The results demonstrate that, under the influence of 
trypsin, the model-dipeptide had been coupled to the C-ter-
minal arginine residue of the l\le-protected fragment (1-38) 
of cytochrome c. From fraction A, 8 mg of the tetraconta-
peptide derivative could be isolated, uhich corresponds to 
a yield of 37^ for the enzymatic reaction, 
The enzymatic synthesis urns studied with a N -protec­
ted heme peptide because masking of the positively charged 
lysyl side chains should prevent tryptic hydrolysis of pep-
90 
tide bonds adjacent to lysyl residues. In order to inves­
tigate, to what extent this side chain protection is necessa­
ry under the conditions for peptide bond synthesis, the ex­
periment was repeated, employing the unprotected heme frag­
ment (1-3Θ) of cytochrome c. Gelfiltration of this reaction 
mixture showed a large number of peaks. Apparently the heme 
fragment had been partially hydrolyzed during the incubation 
with trypsin in the soluent mixture. It must be concluded 
that even under conditions that favour peptide bond synthe­
sis, it is required that only a single bond is susceptible 
to the action of the enzyme. This implied that our first 
attempt to couple the heme fragment (1-3B) with larger pep­
tides had to be done uith completely NE-protected sequences. 
The couplings of the l\le-protected fragments (39-65) and 
(39-104) uiith the l^-protected heme fragment (1-3Θ) of cyto­
chrome с were investigated using the same procedure as des­
cribed for the coupling of the model dipeptide uith the heme 
fragment of cytochrome c. Both non heme fragments, contain 
a tryptophan residue at position 59, so that the introduc­
tion of such a fragment in the heme peptide could easily be 
established by U.U. spectroscopy. Ноше ег, spectral analysis 
of the heme peptide fractions, obtained by gelfiltration of 
the enzymatic reaction mixtures, gave U.U. spectra which 
were identical with those, recorded for fraction В in the 
model-experiment. Apparently, the enzymatic method failed 
in the couplings of the two non heme fragments with the heme 
fragment. A change of the composition of the solvent mixture 
from 50% aqueous dimethylformamide to 85% aqueous glycerol, 
which was frequently employed by Laskowski et al. (13,14,15) 
did not cause any improvement. 
As already mentioned in the introduction of this chap­
ter, the formation of a noncovalent complex between two pro­
tein fragments, to be coupled, may be an essential step in 
the performance of the intended condensation. Such a complex 
is formed, indeed, between the two unprotected, complementary 
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tryptic fragments of cytochrome с (see Chapter III). Ηοω-
ever, treatment of such a complex with trypsin, employing 
the conditions described in this chapter, results in an al­
most complete tryptic hydrolysis of the protein fragments, 
as expected. On the other hand, masking of the side chain 
amino groups, necessary to eliminate this hydrolysis, pre­
vents the formation of a molecular complex and this might 
be the reason for the failure of the enzymatic fragment 
condensation method. 
Another explanation for the failure to couple the tuo 
large protein fragments enzymatically, might be that the so­
lubility of the nan heme fragments is much louer than that 
of the model-dipeptide, so that the large excess of nucleo-
philic peptide which is employed in the model-experiment 
(45 equivalents), can not be reached. 
Taking these considerations into account, the combina­
tion of the fisc-protection for the lysyl side chain functions 
of the fragments (1-38) and (39-104) and the use of trypsin 
as a peptide bond synthesizing enzyme seems not to be a 
promising procedure for the semisynthesis of cytochrome c. 
It might be that the use of a proteolytic enzyme which hy-
drolyzes preferentially arginyl peptide bonds, uiz. clos-
tripaine, offers more perspective for the enzymatic coupling 
of the fragments (1-38) and (39-104), because the fragments 
can then be used in the unprotected form. 
Since the enzymatic method works well, when a small 
nucleophilic peptide can be used in large excess - efg., 
the protected ACTH-(7-10)-tetrapeptide, Msc-Phe-Arg-Trp-Gly-O 
could be prepared by a tryptic catalyzed condensation of the 
two partially protected dipeptides -, another alternative 
might be a procedure based on a chemical carboxyl group acti­
vation of the heme fragment by enzymatic coupling. So it migh 
be supposed that a tryptic catalyzed condensation of H-(L)-
Lys(nsc)-N2H2-Boc with the N
e
-protected fragment (1-38) might 
offer the possibility of an azide fragment condensation of 
2 
the activated fragment (1-39) and a fragment (40-104), both 
in unprotected form, after they haue been combined in a mo­
lecular complex. 
Ноше ег, it may be that the clostripaine catalyzed 
coupling as uiell as the suggested azide coupling, are fore­
doomed to failure because the sequence corresponding to the 
residues (39-58) in the noncoualent complex might choose 
another conformation as in native cytochrome c,(as was out­
lined in Chapter III). In that case the terminal residues of 
the broken bond should be kept at a distance which prevents 
the restoration of the peptide bond by the above suggested 
coupling procedures. 
Because of these considerations, it uas decided to stop 
the efforts, aimed at covalent restoration of the Arg -Lys 
peptide bond in the noncoualent complex (1-38):(39-104), and 
to continue the investigation uith a study of noncovalent 
complexes in uhich tryptophan 59 has been uaried. This study 
is described in the next chapters. 
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C H A P T E R U 
INVESTIGATIGNS INTO Д SEMISYNTHESIS OF THE 
FRAGMENT (59-104) OF CYTOCHROME С 
U.I. INTRODUCTION 
In the previous chapter it has been shown that the 
conversion of the noncovalent complex (1-38):(39-104) , 
which properties have been described in chapter III, into 
a corresponding, covalent species involves very serious 
difficulties. The enzymatic method for the formation of 
peptide bonds also failed in the coupling of the tryptic 
fragments (1-38) and (39-104) of cytochrome c. 
As uas discussed in the previous chapter, an explana 
tion of these results might be that in the tertiary struc 
ture of cytochrome c, the fragment containing the residue 
(39-58) is present as a peripheral loop and it is outline 
in chapter III that it may be that this part of the se­
quence in the complex chooses another, more undefined, or 
even wrong conformation in which the terminal residues 
belonging to the broken bond are kept at a distance which 
prevents restoration of the peptide bond. If this is true 
the difficulties encountered in the conversion of the com 
plex (1-38):(39-104) into cytochrome с may be rather gene 
ral to semisynthetic procedures, considered for the prepa 
ration of cytochrome с analogues, varied in or in the nei 
bourhood of the critical sequence (39-58). 
Because of this consideration and in view of the hig 
stability and high biological activity of the complex (1-
38):(39-104) it was decided to continue the investigation 
with a study of noncovalent complexes, varied at position 
59. The most simple possibility seemed to be the investi-
gation of (1-38) : ( 59-104) complexes in ujhich the sequence 
(39-5B) has been completely left out. 
In this chapter a strategy is planned and investiga­
ted for the semisynthesis of the fragment (59-104) of cyto­
chrome c. It involves the use of the natural fragment (66-
104), which шаз available from cyanogen bromide cleavage 
of cytochrome с (chapter II). 
V.1.1. Strategy for a semisynthesis of fragment (59-104). 
In designing a strategy for a semisynthetic procedure 
for the fragment (59-104) it seems obvious at first sight 
to synthesize a heptapeptide corresponding to the sequence 
(59-65) and to condense this with the available cyanogen 
bromide fragment (66-104). Ноше ег, in the synthesis of the 
heptapeptide, the presence of a C-terminal methionine re­
sidue causes experimental and strategic difficulties, viz.: 
the possible oxidation of the methionine residue to its 
sulfoxide during the synthetic procedures and the fact that 
catalytic hydrogénation for the removal of benzyloxycarbo-
nyl protecting groups (see section U.I.2.) can not be em-
ployed. 
Therefore, a final strategy was chosen, which involves 
the coupling of a synthetic hexapeptide-hydrazide corres-
ponding to the sequence (59-64) with the fragment (66-104) 
which was previously elongated with methionine via an active 
ester coupling; a similar strategy has been applied at the 
semisynthesis of the fragment (66-104) from a synthetic 
fragment (66-79) and an isolated fragment (B1-104) which 
was also elongated before with methionine by an active 
ester coupling (1). 
Msc-groups were chosen for the protection of the amino 
functions in the synthetic hexapeptide derivative because 
they are stable to the conditions necessary for the removal 
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of Ζ-, Boe- and -OBut protecting groups (see section U.1.2.) 
and because all protecting groups can be remov/ed after the 
final coupling in one step by a short base treatment. Scheme 
U.I.I, illustrates the strategy, proposed for the semisyn-
thesis of the fragment (59-104). 
(Msc)<e (Msc)., 
1 CNBr , 1—=—. 
-io¿|-OH • H -{ев юц-сн 
Boc-Met-OpFp 
(Msc). 
Вое 465- HÖ I^-OH 
TFA 
Msc (Msc). 
ι I B 
Msc-)59-6*l-N, • H-|65 JÖZl-OH 
synthetic 
(Msc^ 
Msc-jä1 ^Щ^Н 
base 
Н-|5Э -Ш|-0Н 
Scheme U.1.1. Strategy for the semisynthesis of the 
fragment (59-104) of cytochrome c. 
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U.I.2. Method of synthesis of the partially protected 
cytochrome с (59-64) hexapeptide hydrazide. 
V.1.2.1. Introduction. 
The principal reaction in the synthesis of peptides 
is the formation of an amide bond by acylation of the 
α-amino group of an amino acid or peptide with the a-carbo-
xyl group of another amino acid or peptide. In general this 
reaction involves the activation of the a-carboxyl group of 
an amino protected amino acid or peptide, folloued by amino-
lysis of this activated derivative by a carboxyl protected 
amino acid or peptide (scheme V.1,2.1.1.). 
X-SH-CH-CO-A . HjN-CH-CO-Y • 
X-NH-OKO 
H-N-CH-CO-Y 
• X-I+KH-CO-MH-CH-CO-Y . HA 
Scheme U.I.2.1.1. X, amino protecting group; Y, 
carboxyl protecting group; A, activating substituent. 
It is clear that the protecting groups used in pep­
tide synthesis must be stable under the conditions of the 
coupling step, and on the other hand must be removable 
without cleavage of peptide bonds. In the synthesis of larger 
peptides it is necessary to have the disposal of several, 
selectively removable protecting groups for the same func­
tion. Only in this uiay a protected terminal function of 
some intermediate peptide can be liberated for the next 
coupling step ujithout loss of protecting groups in corres­
ponding side-chain functions (2). 
Three useful protecting groups for amino functions, 
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idhich meet these conditions, are the benzyloxycarbonylgroup, 
introduced by Bergmann and Zeruas in 1932 (3), uihich is la-
bile to catalytic hydrogénation, the tert-butyloxycarbonyl 
group, introduced by Carpino in 1957 (4), which is cleaved 
by trifluoroacetic acid but resists catalytic hydrogénation, 
and the methylsulfonylethyloxycarbonyl group, introduced 
by Tesser in 1975 (5), which is acid stable and resists 
catalytic hydrogénation but can be removed by a short and 
mild alkali treatment. 
The most general method for reversible blocking of 
carboxyl groups is esterification (l). The alkali-stable 
tert-butyl ester (6) and the alkali-labile methyl ester 
(7) are examples of frequently applied carboxyl-protecting 
groups. 
A very elegant procedure for the protection of termi-
nal carboxyl groups is the carbodiimide mediated reaction 
with an M-acyl hydrazide (θ), e.g. tert-butyloxycarbonyl 
hydrazide, used by Schuiyzer (9), The elegancy originates 
from the possibility to convert this protecting group into 
an active acyl function,viz. an azide, without racemisation 
and without intermediacy of the free carboxylic acid (1d.) 
(scheme \J, 1 . 2.1 . 2. ) ; the use of azides is an attractive pro­
cedure in amino acid and peptide condensations, since their 
introduction by Curtius in 19D2 for this purpose (10). 
Boc 
/ 
N-N 
/ \ 
Η Η 
2 NO* — f 
Scheme U.I.2.1.2. 
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U.1.2.2. Strategy. 
Because the cytochrome с (59-6A)-hexapeptidet according 
to scheme U.I . 1 . , had to be coupled ujith the ( 65-1 04)-sequence 
in a subsequent step, it uas decided to prepare the hexa-
peptide as a protected hydrazide. This choice permits res­
tricted side chain protection in the final coupling step 
and even the use of the fflsc-amino protecting group, although 
this is sensitive to hydrazinolysis. A second consideration 
used in the planning of the synthesis of the hexapeptide 
uas that the method had to be employed for the preparation 
of a series of hexapeptides, having various amino terminal 
residues (position -59). 
Therefore ue planned the synthesis of a suitably pro­
tected pentapeptide derivative, containing the common se­
quence (60-64) and apt for final condensation with amino 
acid residues at position -59. It ums obtained by a frag­
ment condensation betueen two dipeptide derivatives corres­
ponding to the residues (61-62) and (63-64) and a stepwise 
elongation, introducing residue -60 (scheme U.I.2.2.) 
All intermediate α-amino functions шеге protected with 
the benzyloxycarbonyl group whereas the ε-amino function 
and the α-amino function of residue -59 шеге protected with 
the methylsulfonylethyloxycarbonyl group. Tert-butyl esters 
were used for protection of the carboxylic side chain func­
tions. 
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59 60 61 62 63 64 
Тгр Lys Glu Glu Th г Leu 
Msc-
Msc-
Msc-
Msc-
Z-
-OH ζ 
-Otcp Η 
OBut 
Z-^ONSu H-
L 
Msc ONp 
~OH 
Msc 
Msc 
-L· 
-L 
OBut L 
OBut 
L / 
OBut 
L 
L OBut 
.OBut 
L 
.OBut 
Msc 
Msc 
OBut 
.OBut 
OMe Z-f-OMe Z--
,OBut 
OMe Z-
,OBut 
OMe Z-
,OBut 
L 
.N2H3 H-
,OBut 
L 
,OBut 
L OBut 
.OBut 
L 
L ,OBut 
Z--OH 
м2НзН-
Scheme U.l.2.2. Strategie scheme for the synthesis of 
the partially protected cytochrome с (59-64)-hexapep-
tide hydrazide. 
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V.2. RESULTS AND DISCUSSION 
Synthesis of the partially protected hexapeptide hy-
drazide was carried out according to scheme U.I.2.2. Z-
Glu(0But)-Glu(0But)-0Me was prepared as described by Moroder 
and üJünsch (11), who used this peptide derivative as an in-
termediate in the synthesis of human minigastrin I, Upon 
hydrazinolysis of this methyl ester, the dipeptide deriva-
tive uas coupled ujith H-Thr-Leu-I\l:;,H:,-Boc, via the Honzl 
and Rudinger method (12). The latter dipeptide derivative 
uias obtained by an azide coupling of Z-Thr-N, and H-Leu-
Ν-,Ηρ-Βοο, folloued by catalytic hydrogénation. After cata-
lytic hydrogénation of the resulting protected tetrapeptide 
derivative, it uas elongated with Z-Lys(Msc)-0Np (method a.) 
or with Z-Lys(lvlsc)-OH using a mixed anhydride coupling 
(method b.) (13, 14). 
The purification of the product obtained via method 
a. was rather laborious; a gelfiltration on Sephadex LH-
20 appeared to be necessary. The purification of the pep-
tide derivative obtained via method b. was considerably 
easier. Elongation of the pentapeptide derivative was accom-
plished, after catalytic hydrogénation, using an active 
ester coupling with Msc-Trp-GtCp. The type of activating 
function uas selected to yield a readily crystallizable de-
rivative. The excess active ester could well be separated 
from the protected hexapeptide by Sephadex LH-20 gelfiltra-
tion. 
The protected hexapeptide uas partially deprotected 
ujith 90% (v/v) trifluoroacetic acid. The elimination of 
But and Boc groups proved to be complete ujithin 45 min. 
at +4 C. Although the risk of tert-butylation of the tryp-
tophyl residue exists (15), such side products could not 
be detected. Apparently the water content (10$ (v/v)) is 
sufficient to eliminate side reactions. All intermediates 
in the synthesis шеге obtained as homogeneous compounds 
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(T.L.C.); they шеге characterized by elemental analyses 
and NMR-spectroscopy (see table V.3.I.). 
In order to establish the usefulness of the partially 
protected hexapeptide hydrazide (XII) for condensations via 
the azide method, it uas coupled with H-Tyr-OMe. This amino 
acid derivatiue шаз chosen as the amino component in the 
model-experiment because its incorporation into the hexa­
peptide derivative can be easily detected by the determina­
tion of the tyrosine/tryptophan ratio in the product isola­
ted idith the method of Bencze and Schmidt (IB). It appeared 
that a peptide derivative could be isolated in B6% yield, 
having a tyrosine/tryptophan ratio of 0.93. From this it 
can be concluded that an active azide function is present 
in the hexapeptide derivative XII under the coupling con­
dition. 
The elongation of the N -protected cytochrome с frag­
ment (66-104) with a methionine residue was done by an ac­
tive ester coupling, using Boc-Met-OpFp (17). The presence 
of methionine -65 in the product XIII could be demonstrated 
by amino acid analyses. From table U.2.1. it appears that 
the amino acid analyses of the partially protected frag­
ment (66-104), before and after dinitrophenylation, showed 
the expected difference of one glutamic acid residue, cau­
sed by reaction of the α-amino function of the N-terminal 
glutamic acid residue -66 uiith fluorodinitrobenzene. After 
the elongation with methionine -65, the values obtained 
for glutamic acid, before and after dinitrophenylation, 
appeared to be equal and the value for methionine was in­
creased with one residue as compared to the value obtained 
for the fragment before coupling with methionine. 
After having obtained the desired components for the 
final coupling step, in a suitably protected and well de­
fined form, their conversion into the intended N-protected-
(59-104)-sequence was attempted. Although it was demonstra­
ted that the peptide derivative (59-64) could be elongated 
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C-terminally with a simple amino acid residue, the coupling 
of the partially protected hexapeptide-hydrazide-(59-64) 
with the partially protected fragment (Б5-104) could not 
be achieved. When the reaction mixture uas subjected to gel-
filtration, tuo peaks were eluted from the column. Spectro­
scopic analysis of the peaks revealed that the first peak 
contained no tryptophan whereas the second peak showed a 
typical tryptophan spectrum in the range of 30Q-27Q nm. 
It must be concluded that the former peak contains the un-
reacted fragment (65-104) and the latter peak the hexapep-
tide. Increase of the reaction time to 2.5, 5 or S days 
or enlargement of the excess of the azide from 5 to 10 
equivalents or reduction of it to 1.5 or 1.2 equivalents 
did not effect the product composition. 
A possible explanation for this behaviour might be the 
unavailability of the sole amino group in the partially 
protected fragment (65-104), as a consequence of a prefe­
rential conformation of the relevant peptide derivative, 
in which the N-terminal region is masked against the inter­
action with any azide; this should prevent the coupling be­
tween the two peptide derivatives. 
Another cause of the failure of the reaction might be 
that the reactants differ too much in polarity. It can not 
be excluded that a more apolar hexapeptide derivative -
in which the glutamic acid side chains are protected as 
t-butylesters and the hydroxyl group of threonine as a t-
butylether - should be a more promising reaction partner 
for the partially protected fragment (65-104) because the 
reaction sites are brought better together by hydrophobic 
interactions, 
This has not been investigated, however. Ue have cho-
senanother strategy for the semisynthesis of (59-104) se­
quences, which is described in the next chapter. 
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Table U.2.1,* Amino acid analyses of the Ν ε -protec­
ted fragment (66-104), before (B) and after (A) elon­
gation uiith methionine -65, 
Residue 
Asp 
Thr 
Glu 
Pro 
Gly 
Ala 
iï)etb· 
Ile 
Leu 
Туг 
Phe 
ІЧНз 
Lys 
Arg 
3.05 
2.B8 
5.1 
1.92 
2.04 
3.27 
0.77 
3.B6 
3.13 
2.70 
0.97 
3.45 
7. 1 
1.12 
В 
а. 
2.95 
2.83 
4.12 
1.9 
2.01 
3.17 
0.73 
3.73 
3.DB 
— 
0.95 
2.32 
7.6 
1.06 
2.89 
2.BI 
5.07 
2.01 
2.16 
3.29 
1.82 
3.66 
3.00 
2.81 
0.99 
3.55 
7.51 
1.08 
А 
а. 
3.05 
2.90 
5.01 
1.97 
2.13 
3.35 
1.70 
3.81 
3.12 
— 
1.05 
3.32 
7.61 
1.01 
Theoretical values correspond to the nearest integer; 
no corrections mere made for loss on hydrolysis. 
a.after dinitrophenylation 
b,methionine-sulfoxide included 
107 
U.3. EXPERIMENTAL 
M,3.1. General procedures. 
Thin layer chromatography шаз performed on precoated 
fluorescent silica plates (Merck F254). To develop the 
chromatograms, the following solvent systems uere used: 
A. chloroform-methanol-acetic acid (95:2D:3) 
B. 1-butanol-acetic acid-uater (4:1:1) 
C. chloroform-acetone (1:1) 
D. chloroform-methanol (9:1) 
The compounds шеге detected by fluorescence quenching or 
by spraying the plates uith ninhydrin, T.D.M. solution (18) 
or the reagent of Ehrlich. 
Specific rotations шеге measured uith a Perkin-Elmer 
241 Polarimeter. Spectroscopic measurements шеге performed 
uith а Сагу IIB instrument. N.M.R. spectra шеге recorded 
uith a Bruker 90 MHz instrument using T.M.S. as standard. 
Column eluates шеге monitored uith an LKB Uuicord Type S 
instrument and amino acid compositions шеге determined uith 
a modified Jeol JLC-GAH analyzer after hydrolysis of the 
samples in 5.7 N hydrochloric acid (Merck suprapur) at 110 -
115° С for 24 hrs in sealed evacuated tubes. 
V.3.2. Synthesis of the partially protected cytochrome c-
(59-64)-hexapeptide hydrazide. 
L-Tryptophan uas protected uith methylsulfonylethyl 
p-nitro-phenyl carbonate as described by Tesser et al. (5). 
The resulting methylsulfonylethyloxycarbonyl-(L)-tryptophan 
(0.53 g, 1.5 mmoles) uas treated uith 0.30 g (1.5 mmoles) 
of 2,4f5-trichlorophenol and 0.31 g (1.5 mmoles) of dicyclo-
hexylcarbodiimide in ethyl acetate. After 1 hr. at Q0C and 
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16 hrs. at room temperature the precipitate was filtered 
and the filtrate evaporated in uacuo to dryness. The pro­
tected active ester шаз crystallized from isopropylalcohol. 
Yield 0.Б g (75%); RF=Q.74 (A); m.p.=190oC; [a]2D=-36.60 
(c=1.3t DflF); C 2 1H l gN 20 6Cl 3S 
caled.: С 47.25^, H 3.59^, Ν 5.25% 
found : С 47.3 %, Η 3.5 %, Ν 5.3 % 
Z-(L)-Leu-l\l2H2-Boc (il) 
Upon treatment of benzyloxycarbonyl-(L)-leucine (19) 
with dicyclohexylcarbodiimide, N-hydroxybenzotriazol (20) 
and t-butyl-carbazate (4) in ethyl acetate, II шаз ob­
tained as an oily substance. Yield 93% (lit. (21) 81%). 
H-(L)-Leu-l\l2H2-Boc (ill) 
Hydrogénation of II in the presence of palladium on 
charcoal in methanol gave a solid material, which could be 
crystallized from ethyl acetate. Yield 100%; m.p.=1120C-
1130C; [α]20
=+
2ΐ.2ο (c=1.1, MeOH),(lit. (22)tyield 47% 
(calculated on Z-(L)-Leu-DH); m.p.=1120-1140C; [а]ц0= 
+21.77° (c=2.35, MeOH)). 
Z-(L)-Thr-N2H3 (IV) 
The hydrazide шаз obtained by hydrazinolysis of the 
methyl ester of benzyloxycarbonyl-(L)-threonine (23) with 
hydrazine-hydrate in methanol. Yield 6Θ%; [a ]^ =-11.2° 
(c=0.81t HOAc), (lit. (23, 24), yield 76%; [a]p
D
=-11.3° 
(c=1, HOAc)). · 
Z-(L)-Thr-(L)-Leu-N2H2-Boc (U) 
A solution of 1.34 g (5 mmoles) of the hydrazide I\I 
in 25 ml of dimethylformamide was cooled to -40 C. After 
addition of 4.5 ml (15 mmoles) of a 3.33 N solution of 
HCl in dry ethyl acetate and 0.72 ml (6.25 mmoles) of tert-
109 
butyl nitrite, the solution шаз allouée) to stand at -25 С 
for 5 min. and cooled again to -40 C. The reaction mixture 
was neutralized by addition of N-ethyldiisopropylamine and 
supplied with 1.47 g (6 mmoles) of the aminocomponent III, 
dissolwed in 5 ml. of dimethylformamide. 
After 22 hours at +4 C, the mixture шаз concentrated 
in uacuo and the residue uas dissolwed in ethyl acetate. 
The solution was extracted with 2 N potassium hydrogen sul­
fate, 2 N potassium hydrogen carbonate and saturated sodium 
chloride solutions. The ethyl acetate layer was dried over 
anhydrous sodium sulfate, filtered and then evaporated in 
vacuo to dryness. An oil remained which solidified on 
drying in vacuo. Yield 2.18 g (91%); RF=D.66 (А), Рр= 0.83 
(Β); [α]ρ0=-49.8ο (c=0.B4, NeOH); C ^ H ^ N ^ . ^ G 
caled.: С 56.43%, Η 7.52%, Ν 11.44% 
found : С 56.4 %, Η 7.6 %, IM 11.4 % 
¿zítl:2iyl9Eb!i2zík2=£iyí2§Hílr9!ü!2_Í^Il 
Catalytic hydrogénation of Z-(L)-Glu(0But)-0Me (25) 
in methanol and treatment of the resulting product with 
Z-(L)-Glu(0But)-0NSu (26) in dimethylformamide for 24 hrs 
gave the desired protected dipeptide derivative in 86% 
yield. m.p. = 510-520C; [α ]QD=-19.8° (c=1.15, MeOH), (lit. 
(27) m.p.= 460-470C; [α ]Q0=-19.4° (c=1, MeOH); lit. (11) 
m.p. = 48o-50oC, [<* J^-l 8.1° (c=1, ΓΊεΟΗ)). 
Z-(L)-Glu(0But)-(L)-Glu(0But)-M2H3 (VII) 
To a solution of 1.07 g (2 mmoles) of VI in 2.5 ml of 
methanol 0.29 ml (6 mmoles) of hydrazine hydrate were added. 
The solution was left for 24 hours at 450C. After addition 
of 50 ml of water, the hydrazide precipitated. The precipi­
tate was filtered, crystallized from methanol/water (1:2) 
and dried in vacuo. Yield 0.96 g (90%); Р
р
=0.71 (В), 
RF=0.29 (D); [α]2
0
=_23.9ο (c=0.91, WeOH); С^Н^МдОд 
caled.: С 58.19%, Η 7.51%, Ν 10.44% 
found : С 57.9 %, Η 7.4 %, Ν 10.2 % 
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Z-(L)-Glu(0But)-(L)-Glu(0But)-(L)-Thr-(L)-Leu-l\l2H2-Boc (UHI) 
В5Э mg (1.6 mmoles) of the hydrazide Uli шеге dissol­
ved in 6 ml of dimethylformamide and the solution шаз coo­
led to -40oC. 1.6 ml (4.8 mmoles) of a 3 N solution of HCl 
in dry ethyl acetate and 0.23 ml ( 2 mmoles) of tert-butyl 
nitrite шеге added, and the mixture шаз left for 5 min. at 
-250C. Then the solution was again cooled to -40 C, and 
neutralized by the addition of l\l-ethyldiisopropylaminet and 
supplied iiiith 3 ml of a DMF solution, which contained 606 mg 
(1.75 mmoles) of the amino compound obtained by hydrogeno-
lysis of 841 mg (1.75 mmoles) of V. 
After 2.5 days at +40C the solution was concentrated 
in vacuo, ethyl acetate was added, and the resulting mixture 
was extracted with 2 N potassium hydrogen sulfate, 2 N po­
tassium hydrogen carbonate and saturated sodium chloride 
solutions. The ethyl acetate layer was dried over anhy­
drous sodium sulfate, filtered and evaporated in vacuo to 
dryness. The residue solidified on drying in vacuo but did 
not crystallize. Yield 1.33 g (98%); Rf=0,75 (A), Rf=0.4 
(D); [α]20
=
_45.3ο (с=0.Э5, ПеОН); С
Д 1 HggNgO., 3. ¿Н20. 
caled.:С 57.26$, Η 7.73%, Ν 9.77$ 
found :C 57.2 %, Η 7.8 %, Ν 9.5 % 
A solution of 0.86 g (2 mmoles) of Z-( L)-Lys(rOsc)-
0H(5) and 0.45 g (2.2 mmoles) of p-nitrophenol in 15 ml 
of acetonitrile was cooled to 0 C. Then 0.43 g (2.1 mmoles) 
of dicyclohexylcarbodiimide were added. After 1 hr at 0 С 
the solution -was left for 16 hrs at room temperature. The 
precipitated dicyclohexylurea was removed by filtration 
and the filtrate was evaporated to dryness in vacuo. Upon 
treating the resulting yellow oil with isopropylalcohol, 
the product crystallized. The crystals were filtered, washed 
with isopropylalcohol and recrystallized from warm isopro­
pylalcohol. Yield 0.97 g (85$); RF=0.6B (A); [α ]^Q=-13.6° 
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( с = О . , d i o x a n ) ; С, 
c a l e d . : С 5 2 . 2 6 % , H 5 . 3 0 % , Ν 7 . 6 2 % 
' 2 4 H 2 9 N 3 D 1 0 S · 
f o u n d 5 2 . 2 %, H 5 . 2 Ν 7 . 6 % 
L e u - l \ l 2 H 2 - B o c ( Χ ) 
m e t h o d a . 
42.5 mg (0.05 mmoles) of UHI, dissolved in 5 ml of 
methanol, шеге hydrogenated in the presence of palladium 
on charcoal. After remoual of the catalyst by filtration, 
the solution was evaporated to dryness in vacuo. The resi­
due шаз dissolved in 2 ml of dimethylformamide, and 34 mg 
(0.06 mmoles) of IX шеге added to the solution. 
After 5 hrs at room temperature the yellou solution 
шаз applied to a column of Sephadex LH-20 (120 χ 2.5 cm) 
equilibrated ujith dimethylformamide. The peptide derivatives 
шеге eluted uith dimethylf ormamide luith a flow rate of 24 
ml/hr. Fractions of 6 ml шеге collected. The fractions, 
comprising the first peak, шеге pooled and evaporated to 
dryness in vacuo. The residue шаз dissolved in ethylacetate. 
After addition of diisopropylether the desired product pre­
cipitated. Yield 35 mg (62%); Р
р
=0.73 (A). 
method b. 
A solution of 0.71 g (1.65 mmoles) of Z-(L)-Lys(l4sc)-
0H(5) and 0.21 ml (1.65 mmoles) of N-ethylmorpholin in 
2 ml of dimethylformamide шаз cooled to -15 C. Then 0,20 ml 
(1.54 mmoles) of isobutyloxycarbonylchloride шеге added. 
After 2 min, a solution of 1.1 mmoles of the amino compound 
(obtained via hydrogénation in methanol of 936 mg (1.1 
mmoles) of l/III in the presence of palladium on charcoal) 
in 2,5 ml of dimethylformamide шаз added, and the mixture 
шаз left at -10oC for 2 hrs. 
In order to hydrolyze the excess of the anhydride 
1.65 ml of a 2 N potassium hydrogen carbonate solution шеге 
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added and the mixture шаз left for D.5 hr at room tempera­
ture. Upon addition of 20 ml of a 75% saturated sodium chlo­
ride solution in water, a sticky precipitate was obtained 
which was collected by centrifugation. The precipitate was 
washed with water and dried in wacuo. The peptide derivative 
bias obtained in a chromatographically pure form by crystalli­
sation from ethylacetate. Yield 1.11 g (ВЭ. ^ ) ; RF=0.73 (A); 
" "20 
α JL^
U
=-4Q.G0 (c=1.0, PleGH); C^ H^NgO., gS.^O. 
caled.: С 53.81$, H 7.53$, Ν 9.Β4$ 
found : С 53.8 %, Η 7.5 %, Ν 9.8 % 
Thr-(L)-Leu-l\l2H2-Boc (ΧΙ) 
0.34 g (0.3 mmoles of Χ were hydrogenated in metha­
nol in the presence of palladium on charcoal. After fil­
tration of the catalyst the solution was evaporated to dry­
ness. The residue was dissolved in 5 ml of dimethylformami-
de and 0.35 mmoles of I were added. After 24 hrs at room 
temperature, the solution was applied to a Sephadex LH-20 
column (120 χ 2.5 cm) equilibrated with dimethylformamide. 
The peptide derivative was eluted with dimethylformamide 
with a flow rate of 24 ml/hr. Fractions of 6 ml were col­
lected. Fractions comprising the first peak were pooled and 
evaporated in vacuo to dryness. 
The residue was dissolved in methanol. After addition 
of diisopropylether (+ 3 volumes) the protected hexapeptide 
derivative (XI) crystallized in a chromatographically pure 
form. The precipitate was collected by centrifugation, 
washed with diisopropylether, and dried in vacuo. Yield 
74$; RF=0.63 (A); [a ]QD=-31.2° (с=0.95, МеОН); 
C58 H94 N10 021 S2* C H3 0 H· 
caled.: С 51.96$, H 7.24$, Ν 10.26$ 
found : С 52.2 $, Η 7.2 $, Ν 10.0 $ 
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Thr-(L)-Leu-N2H2-Boc (Xi) 
D.34 g (0.3 mmoles) of X шеге hydrogenated in methanol 
in the presence of palladium on charcoal. After filtration 
of the catalyst the solution was evaporated to dryness. The 
residue шаз dissolved in 5 ml of dimethylformamide and 0.35 
mmoles cf I шеге added. After 24 hrs at room temperature, 
the solution was applied to a Sephadex LH-20 column (120 χ 
2.5 cm) equilibrated with dimethylformamide. The peptide 
derivative шаз eluted with dimethylformamide with a flow 
rate of 24 ml/hr. Fractions of 6 ml шеге collected. Frac­
tions comprising the first peak шеге pooled and evaporated 
in vacuo to dryness. 
The residue шаз dissolved in methanol. After addition 
of diisopropylether (+ 3 volumes) the protected hexapeptide 
derivative (Xl) crystallized in a chromatographically pure 
form. The precipitate шаз collected by centrifugation, 
ujashed with diisopropylether, and dried in vacuo. Yield 
74$; RF=0.63 (A); [a ]^0=-31 .2° (c=0.95, CleOH). 
C58H94M1Ü021S2-CH3DH· 
caled.: С 51.96$, Η 7.24$, Ν 10.26$ 
found : С 52.2 $, Η 7.2 $, IM 10.0 $ 
^SSzíklrlEElÍLlztZ^ÍÍÍIS^lzÍLlzCiüzíklzGlu-iLi-Thr-^L)-
Leu-I\I2H3 (XII) 
100 mg of XI шеге dissolved in 10 ml of precooled 90$ 
(v/v) trifluoroacetic acid. After 45 min at 0 C, icecold, 
dry diethyl ether шаз added, and the precipitate шаз cen-
trifuged, iijashed luith dry diethyl ether, dried in vacuo, 
dissolved in cone, acetic acid, and lyophilized. Yield 92$; 
RF=0.32 (В); [
а]ц0=-11.5О (c=0.72, MeOH) 
114 
V.2.3. Elongation of the partially protected fragment 
66-104 with methionine. 
.,
a
 r, .,ε-72.73.79.86-88.99.100 . „ . 
N -Boc
z
 N '^ t^ -Jf '^»"^ "о» ^ luu_octa-risc-cytochrome c-
The N -protected cytochrome с fragment (66-104) uas 
isolated and purified as described in Chapter II. 12 mg 
(2 ijmoles) of this purified fragment were dissolved in an­
hydrous trifluoroacetic acid, which шаз subsequently evapo­
rated in a current of nitrogen. The compound шаз dried in 
uacuo over potassium hydroxide. The trifluoroacetic acid 
treated peptide derivative uas dissolved in 200 ul of dime-
thylformamide and the pH of the solution, uas adjusted to 
7,0-7.5 by the addition of !\l-ethyldiisopropylamine. 
Then 25 mg (60 umoles) of Boc-(L)-met-0pFp (17), dis­
solved in 100 Vil dimethylformamide шеге added. After 24 hrs 
the peptide derivative XIII шаз precipitated by the addition 
of a solution of 5% acetic acid in ethyl acetate. The pre­
cipitate шаз collected by centrifugation, washed ujith ethyl 
acetate and diethyl ether, and dried in vacuo (11.7 mg), 
..£-72,73,79,86-88,99,100 .
 m . . ,_,- .
п /ч N _' ^ * ' 2. -octa-Nsc-cytochrome Ç-^65-1.042-
tetracontapeptide ^ХІ ^ 
Compound XIII (11 mg) шаз partially deprotected by 
dissolution in 1 ml of precooled 90% (v/v) trifluoroacetic 
acid. The solution шаз kept at +4 С for 45 minutes. The pro­
duct шаз isolated, after precipitation uith diethyl ether, 
by centrifugation, and dried in vacuo (14.5 mg). 
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V.2.4. Attempted coupling of the partially protected 59-64 
hexapeptide hydrazide (XII) and the partially pro­
tected 65-104 tetracontapeptide (XIU). 
XIV (14.5 mg, 2 ymoles) uias dissolved in anhydrous 
trifluoroacetic acid, which uas subsequently evaporated 
in a current of nitrogen. The residue шаз dried in uacuo 
ouer potassium hydroxide. 12 mg (IG ymoles) of the hydra­
zide XII шеге dissolved in 100 μΐ of dimethylformamide, 
cooled at -20DC, and treated luith dry HCl in ethyl acetate 
(10 yl of a 3 N solution, 30 ymoles) uith stirring, tert-
Butyl nitrite (θ.6 yl of a 2U% (v/v) solution in dimethyl-
formamide, 15 ymoles) шаз then added and the solution шаз 
left for 15 min. at -15ο0. Then the solution шаз cooled to 
-20 С and neutralized by the addition of N-ethyl-diisopro-
pylamine. The solution шаз then supplied with XIV, pretrea-
ted uith trifluoroacetic acid as described above, dissol­
ved in 100 yl of dimethylformamide, and then neutralized 
and cooled at ca. 4 C. The apparent pH of the reaction 
mixture was 7.0-7.5, as indicated by moist pH paper. 
After 16 hrs at +40C, diethyl ether шаз added, and the 
precipitate шаз collected by centrifugation and dried in 
vacuo. The precipitate шаз dissolved in 450 yl of dimethyl-
sulfoxide and the solution шаз diluted uith 150 yl of metha­
nol. 33 yl of a 4 IM solution of sodium hydroxide шеге then 
injected at once. After exactly 40 sec an excess acetic acid 
шаз added and the product шаз precipitated uith diethyl ether, 
collected by centrifugation and dried. The residue шаз dis­
solved in 1% (v/v) formic acid and the mixture was applied 
to a column of Sephadex G-50 fine (2.3 χ 13.5 cm) which was 
equilibrated and eluted with the same solvent at a flow rate 
of 20 ml/hr. Fractions corresponding to the eluted peaks 
were pooled and lyophilized. 
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Table U.3.I.: NMR data of some intermediates in the synthe­
sis of the partially protected (59-64) cytochrome с hexa-
peptide hydrazide; all spectra are taken in CD^OD; chemical 
shifts are quoted in parts per million (ppm) douinfield from 
TPOS. 
1 . Z-Thr-Leu-l\ l 2 H 2 -Boc (U) 
7.34 (s, 5H; aromatic protons - Ζ group); 5.10 (s, 2H; 
methylene protons - Ζ group); 4.60-4,05 (m, 3H; 2a 
protons, 10 -Thr proton); 1.77-1.56 (m, 2H;6-Leu 
methylene protons); 1.45 (s, ЭН; t-Bu protons - Boc 
group); 1.28-1.11 (d, 3H;Y-Thr methylprotons) ; 1.00-
0.Θ3 (m, 6H; S -Leu methylprotons). 
2. Z-Glu(0But)-Glu(0But)-0lvl
e
 (VI) 
7.33 (s, 5h; aromatic protons - Ζ group); 5.09 (s, 
2H; methyleneprotons - Ζ group); 4.56-4.06 (m, 2H; 
α protons); 3.71 (s, 3H; methylesterprotons); 2.44-
1.78 (m, 8H; β -,γ -Glu methyleneprotons); 1.44 (s, 
18H; t-Bu protons - OBut groups). 
3. Z-Glu(0But)-Glu(0But)-N2H3 (Uli) 
Similar spectrum to that of compound VI (2.), except 
that the signal at 3.71 ppm has disappeared. 
4. Z-Glu(0But)-Glu(0But)-Thr-Leu-N2H2-Boc (Vili) 
7.34 (s, 5H; aromatic protons - Ζ group); 5.10 (s, 
2H; methyleneprotons - Ζ group); 4.57-4.05 (m, 5H; 
4a protons, 18 -Thr proton); 2.50-1.80 (m, 8H; 
β-,γ -Glu methyleneprotons); 1,77-1.56 (m, 2H;ß -Leu 
methyleneprotons); 1.44 (s, 27H; t-Bu protons - Boc and 
-OBut groups); 1.28-1.11 (d, 3H;Y-Thr methylprotons); 
1.05-0.90 (m, 6H;6-Leu methylprotons). 
5. Z-Lys(Msc)-0l\l (IX) 
8.34-8,24 (d, 2H; aromatic protons - ON group); 
7.45-7.22 (m, 7H; 2 aromatic protons - ON group, 
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5 aromatic protons - Ζ group); 5.22-5.06 (s, 2H; me-
thyleneprotons- Ζ group); 4.56-4.23 (m, ЗН; 1 α proton, 
2 methyleneprotons - fisc group); 3.50-3.40 (m, 2H; 
methyleneprotons - Msc group); 3.22-3.11 (m, 2H; ε-
Lys methylene protons); 3.01 (s, ЗН; methylprotons -
ІУІзс group); 2.11-1.39 (m, 6H; β-, γ-, 6- Lys methylene­
protons) . 
6. Z-Lys(Msc)-Glu(0But)-Glu(0But)-Thr-Leu-N2H2-Boc (x)· 
7.35 (s, 5H; aromatic protons - Ζ group); 5.11 (s, 
2H; methyleneprotons - Ζ group); 4.55-4.00 (m, ΘΗ; 
5a protons, ÍS -Thr protons, 2 methyleneprotons -
(vise group); 3.46-3.21 (methyleneprotons - Msc group, 
coincide partially with solvent peak); 3.20-3.10 (m, 
2H; ε-Lys methyleneprotons); 3.01 (s, 3H; methylprotons-
Msc group); 2.55-1.95 (m, ΘΗ; 0-, γ- Glu methylene­
protons); 1.95-1.30 (m, 35H; 6β-, γ-, δ-Lys methylene­
protons, 2 β-Leu methyleneprotons, 27 t-Bu protons-
Boc and -OBut groups); 1.25-1.11 (d, 3H; γ-Thr methyl­
protons); 1.11-0.90 (m, 6H; δ-Leu methylprotons). 
7. Msc-Trp-Lys(nsc)-Glu(0But)-Glu(0But)-Thr-Leu-N2H2-Boc (XI). 
7.66-6.95 (m, 5H; aromatic protons Trp (indolyl)); 
4.65-4.00 (т,ізн; Β α protons, 10 -Thr proton, 4 methylene­
protons - Msc groups, 2 0 -Trp methyleneprotons); 3.55-
3,20(methyleneprotons - fisc groups, coincide partially 
uith solvent peak); 3.10-2.90 (d, ΘΗ; 6 methylprotons -
Msc groups, 2ε -Lys methylene protons); 2.44-1.95 
(m, ΘΗ, 0-, γ-Glu methyleneprotons); 1.80-1.30 (m, 
35H; 6 0-, γ-, 6-Lys methyleneprotons, 2ß-Leu methylene-
protons, 27 t-Bu protons - Boc and -OBut groups); 
1.26-1.10 (d, 3H; γ-Thr methylprotons); 1.05-0.B5 
(m, 6H; δ-Leu methylprotons). 
Θ. Nsc-Trp-Lys(Msc)-Glu-Glu-ThT-Leu-N2H3(XIl). 
Similar spectrum as for compound XI (7), except that 
the sharp t-Bu signal at 1.44 ppm has disappeared. 
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C H A P T E R VI 
A BIOLOGICALLY ACTIVE COMPLEX FROM TUO FRAGMENTS OF CYTO­
CHROME C, MISSING THE SEQUENCE (39-58); 
MODIFICATION OF TRYPTOPHAN-59 
VI.1. INTRODUCTION 
VI.1.1. Strategy for the semisynthesis of the fragment 
(59-104). 
In the prewious chapter it was decided to continue the 
inwestigation with a study of noncoualent complexes, compo­
sed of the fragments (1-38) and (59-104) of horse heart 
cytochrome c. In order to study the importance of the role 
of the completely invariant tryptophan residue -59 for the 
biological activity, it was planned to modify this residue 
in the latter fragment (59-104) and to prepare a series of 
such noncovalent complexes, missing the sequence (39-5Θ) 
and only varied at position 59. 
For this purpose a strategy for the semisynthesis of 
fragment (59-104) was proposed and investigated in Chapter 
V, which involves a final coupling of the Νε -protected 
fragment (65-104) with a synthetic Na-t N
e
- protected hexa-
peptide hydrazide, corresponding to the sequence (59-64). 
It appeared however that this coupling presented serious 
difficulties. Therefore the strategy, involving the cyano­
gen bromide fragment (66-104), had to be abandoned. 
At that time, it became clear that cytochrome c, in 
which all amino functions were protected with Msc-groups, 
could be split selectively by an oxidative cleavage proce­
dure, employing a sulfoxide and halo halides (see Chapter II). 
This procedure cleaves only the Trp -Lys (Msc) peptide bond, 
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affording in good yield the fragment (60-104) in шМісЬ the 
sulfur atoms of both methionine residues -65 and -SO hawe 
been oxidized, houever, to the corresponding sulfoxides. It 
turned out that the Msc-protectiue function uas stable to 
the conditions of the cleauage reaction so that the fragment 
(60-104) can be obtained as a selectiuely (^-protected com­
pound, which might be used as an amino component in semi­
synthetic procedures. 
In this chapter, uie describe the preparation of the 
fragment (59-104) by elongation of the S-oxidized and N -
protected fragment (60-104) uiith a suitable tryptophan deri-
uatiue, the remoual of the amino protecting groups from the 
product and the final reduction of the tuio sulfoxide groups. 
Scheme VI.1.1. illustrates the strategy used for the prepa­
ration of the fragment (59-104). 
<Msc)„ 
Ac-f7j -1<K|-0H DMSO/Wr 
(MscL (S-O), 
I э I * 
» H-|60 loZj-OH 
Msc-Trp-Otcp 
(Msc) (S-O, 
, I 9 Ι ι 2 
Msc-|59 IQ I^-OH 
base 
(S-O), l f 
H-|B 104|-OH 
H0OC-CH2-SH 
H-|59 JoZJ-OH 
Scheme VI.1.1. Strategy for the preparation of the 
fragment (59-104) of cytochrome c. 
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The possibility to form a noncoualent complex, con­
sisting of this neuly obtained fragment (59-104) and the 
fragment (1-3B) is then investigated. Some physical and 
biological properties of this complex have been determined 
and compared ujith those of the noncovalent complex (1-38): 
(39-1G4) (see Chapter III) and of native cytochrome c. When 
it uas obvious that the complex (1-3Θ):(59-104) possesses 
a similar activity towards cytochrome c-oxidase as cytochrome 
c, five other sequences (59-104), only modified at position 
59 have been prepared, and complexed uith the fragment (1-38). 
The activities of these complexes towards cytochrome c-oxidase 
have been measured, in order to get more insight into the 
possible role of tryptophan-59 for the electron-transport 
function of cytochrome-c. 
VI.1.2. Tryptophan in cytochrome c. 
The single tryptophan residue in cytochromes с of 
vertebrates has been found to be phylogenetically invariant (1 
This finding suggests an important role for this amino acid 
residue mithin the cytochrome с molecule. 
Tryptophan-59 is situated in close proximity to the heme 
and to two other aromatic residues, viz. the tyrosines-B7 
and -74. The side chain of tryptophan-59 is buried in the 
hydrophobic interior of the cytochrome с molecule and is 
part of a cluster of hydrophobic amino acids that all pack 
tightly around the heme. Moreover, the main chain of tryp­
tophan -59 is hydrogen-bonded to the main chain of the resi­
dues -37 and -38, and the indole N-atom is hydrogen-bonded 
to the inner propionic acid residue of the heme (2, 3). An 
older supposition that electrons are transferred from the 
heme iron to the surface of the molecule via a chain of 
aromatic residues belonging to tyrosines -67 and -74 and 
tryptophan -59 has been abandoned , since a leucine residue 
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has been found at position 74 in cytochrome c-550 of para-
coccus denitrificans (see sec. 1.2.3.) (3,4,5), Later on, 
phenylalanine, tyrosine and leucine residues haue been found 
in functional iso-1-cytochromes с of some mutants of the yeast 
Saccharomyces cereuisiae at position 64, which is homologous 
to position 59 in the uertebrate cytochrome с molecule (6). 
fls a consequence of these observations the role of 
tryptophan -59 has been attributed to the maintainance of a 
large hydrophobic enuelope, surrounding the heme moiety (7). 
The well established participation of tryptophan -59 
in a system of hydrogen bonds in the cytochromes с of verte­
brates has been supposed to be an essential function of the 
residue. This supposition uias supported by the observation, 
that formylation of the NH-group in the indole ring or oxi­
dation of the residue with N-bromosuccinimide - treatments, 
which lead to cytochrome с derivatives incapable to form a 
hydrogen bond with the propionic acid residue of the heme 
group - gave products, uhich appeared to be inactive in the 
depleted mitochondrial system. Moreover, the visible spectra 
of these compounds did not show the characteristic 695 nm 
absorption band of cytochrome c, what points to a different 
tertiary structure (8,9,5). In the functional iso-1-cyto-
chromes с mentioned before, the seemingly essential hydrogen 
bonding can also not occur. 
Summarizing, it may be concluded that the special role 
of tryptophan -59 in cytochrome с is as yet not well esta­
blished, It was our aim to gain further insight into the 
possible function of this residue by the preparation of a 
series of complexes which only differ in the nature of the 
residue at position -59 and the comparison of their biolo­
gical properties. In this investigation we used the tryp-
thophan analogues given in fig. VI.1.2., which have been 
used for a similar purpose in a recent investigation (lu); 
their spatial structure is very similar to that of trypto­
phan, but they differ in hydrophobicity, capability of hydro-
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gen bonding and other physical properties. 
Out ? 
a. X=0; benzofurylalanine, Bfa 
b. X=S; benzathienylalanine, Bta 
COOH c. X==I\1H, 5-monofluoro; 5-fluorotryp-
tophan, Trp (5F) 
d. X=Nb', 6-monofluoro; B-fluorotryp-
tophan, Trp (6F) 
e. X=NHI ^,5,6,7-tetrafluoro; 4,5,5,7-
tetrafluorotryptophan, Trp (tF) 
Fig. UI.1.2. Tryptophan analogues, H-(L)-Xyz-OH, (a-e) 
VI.2. EXPERIMENTAL 
VI.2.1. Materials and general procedures. 
The partially protected fragments corresponding to the 
sequences (1-3B) and (60-104) of horse heart cytochrome с 
(Sigma chemical со., type VI) mere obtained and purified as 
described in Chapter II. The partially protected heme-con-
taining fragment (1-38) could be deprotected by a short 
base treatment and the resulting peptide шаз purified by 
ion exchange chromatography on carboxymethylcellulose. Ex­
perimental details for the deprotection and purification 
have been described in Chapter III. 
The tryptophan analogues H-(L)-Xyz-0H (see fig. VI.1.2.) 
шеге synthesized and resolved as described previously (10). 
Amino protected derivatives of these tryptophan analogues 
(Msc-tL)-Xyz-04) шеге obtained by treatment of the free 
amino acids with methylsulfonylethyl p-nitrophenyl carbo­
nate (11). The Msc-derivati ves шеге then converted into 
2,4,5-trichlorophenyl estsrs by treatment uiith equimolar 
amounts of 2,4,5-trichlorophenol and dicyclohexylcarbodiimide, 
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The general procedures are described in section U.S. for 
tryptophan itself, and they ыеге used without modification 
for all analogues. 
A cytochrome с oxidase preparation (ferrocytochrome c: 
oxygen oxidoreductase, EC 1.9.З.1.), isolated from beef heart 
muscle and purified as described by Hartzeil (12), was a 
gift of Dr. B.F. wan Gelder (В.С.P. Jansen institute, Uni-
uersity of Amsterdam, The Metherlands). 
Experimental details for the monitoring of column 
eluates, U.U.-vis. spectroscopic measurements, the determi­
nation of the temperature dependence of the absorption band 
at 695 nm and the preparation of solutions for spectral 
titrations were described in Chapter III. 
UI.2.2. Preparation of cytochrome c-(59-104)-hexatetracon-
tapeptide. 
α .^60,72,73,79,86-68,99,100 . .. ', , . , .. , a. N -, M f » » » » f -decamethylsulfonylethyl-
oxycarbonyl-cytochrome c-(59-104)-hexatetracontapeptide-
bis-oxide (I). 
The partially protected fragment (60-104) (16 mg, 2.4 
pmoles) шаз dissolved in trifluoroacetic acid, and the so­
lution was re-evaporated in a stream of nitrogen. The residue 
was dried in vacuo over potassium hydroxide pellets, and 
dissolved in 150μ1 of dimsthylformamide. The apparent pH 
of the solution as indicated by moist pH paper, was adjusted 
to 7.0-7.5 by the addition of N-ethyl diisopropylamine. 
Then 40 mg (72pmoles) of Р1зс-( L)-Trp-0tCp were added. The 
solution became gelatinous during the reaction, 
After 18 h. the product was precipitated by the addi­
tion of ethyl acetate (1.5 ml), collected by centrifugation, 
washed in situ with ethyl acetate and diethyl ether, and dried 
in vacuo; yield 16 mg. The same procedure was followed for 
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the incorporation of the tryptophan analogues, flsc-(L)-
Xyz-OtCp. 
b. Cytochrome c-(59-104)hexatetracontapeptide-bis-oxide (II). 
Compound I was dissolved in a mixture of dimethylsulf-
oxide (1.5 ml) and methanol (0.5 ml) and the solution шаз 
treated with sodium hydroxide solution (1.0 Π, 0.5 ml) uiith 
uigorous stirring. After exactly 30 sec. an excess of acetic 
acid (ca. 40 μΐ) шаз injected to neutralize the base. The 
resulting mixture uas filtered through Sephadex G-25 (column 
dimension 35 χ 2 cm) which had been pre-equilibrated with 1 M 
acetic acid. The deprotected peptide was eluted from the 
column with the same solvent mixture. The pertinent fractions 
were combined and lyophilized to yield 14 mg of II. The analo­
gues, compounds in which position 59 had been varied, were 
obtained via a similar procedure. 
c. Cytochrome c-(59-104)-hexatetracontapeptide (III). 
The reduction of the oxidized methionyl residues occuring 
in II at the positions65 and B0 was achieved by addition of 
0.2 ml of mercaptoacetic acid to a solution of 14 mg of com­
pound II in 10 ml of aqueous 6% (v/v) acetic acid. After 24 
h. at room temperature, the solution was applied to a column 
of Sephadex G-25 and the product was isolated as described 
for II. After lyophilization 13.7 mg were obtained. 
VI.2.3. Complexation of the cytochrome с fragments (1-38) 
and (59-104). 
The complexation of the cytochrome с fragments was per­
formed by mixing equimolar amounts of each fragment dissol­
ved in 0.01 molar sodium chloride solution. The stoicheio-
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metry of the complexation reaction was followed by spectral 
titration of a fixed amount of the red, heme-containing 
fragment with increasing amounts of the colourless non-heme 
peptide, as described in Chapter III. 
The complex was isolated by gel filtration through a 
column of Sephadex G-50 fine (column dimensions 185 χ 1.2 cm) 
The gel was pre-equilibrated and eluted with a 0.01 (4 sodium 
chloride solution with a flow rate of 10 ml/h. Fractions of 
2.5 ml were collected. The fractions, containing the nonco-
valent complex were stored at -20 C, or pooled and lyophilize 
VI.2,4. Electron transfer capacity of the complex. 
The reduction of the complex with L-ascorbic acid was 
followed spectrophotometrically at 550 nm. The reaction was 
initiated by injection of an aqueous solution of L-ascorbic 
acid, (100 yl of a 60 m molair solution of L-ascorbic acid, 
buffered at pH 5 by addition of trishydroxymethylamino me­
thane) into 2.5 ml of a 2,5 ymolair solution of the nonco-
ualent complex in 0.01 M sodium chloride. 
Oxidation of the reduced complex was performed with 
cytochrome c-oxidase (12,13). The rate of the reaction was 
determined polarographically by recording the decrease of 
the concentration of oxygen, dissolued in the solutions 
at 25 C. The measurements were carried out using a Clark 
electrode mounted in a jacketed reaction vessel (1.65 ml), 
which was connected to a thermostat. The assay solution 
contained tris acetate (pH 6.8, 25 mM), sucrose (250 mM), 
ascorbate (6 mM), tetramethylphenylencdiamine (1.2 mM), 
Tween-20 (0.1$) and cytochrome c-oxidase (0,145 μΠ). The 
concentration of the cytochrome c-replacing complex was 
varied from 0.04-0,6 yM. 
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υΐ.3. RESULTS AND DISCUSSIDM 
The M -protection of tryptophan and the analogues with 
the Msc-group and the subsequent activation of the protected 
amino acids by conuersion into trichlorophenyl esters шеге 
chosen, because it uas anticipated that these procedures 
should lead to readily crystallizing products. 
Indeed, the N-protected amino acids, isolated as di-
cyclohexylammonium salts (Table І.З.І.), and all end-
products (Table VI.3.2.) шеге obtained as crystalline com­
pounds, which шеге identified by elemental analyses and 
characterised by their R^-ualues and optical rotations. 
The acylation of the l\le-protected and S-oxidized frag­
ment (BQ-1G4) luith Msc-(L)-Trp-OtCp was readily achieved, 
prouiding a large excess of the active ester (30 equiv.) 
was used. The presence of the tryptophyl residue in the pep­
tide derivative I could be inferred spectroscopically from 
the appearance of a shoulder at 2 Б nm. in the U.U. absorp­
tion spectrum. The completeness of the acylation шаз demon­
strated by the method of Bencze and Schmidt (15). This method 
is based on the spectrofotometrical determination of the 
tyrosine/tryptophan ratio. Accepting a tyrosine content of 
3 residues/mole for the starting sequence (60-104), incor­
poration values of tryptophan in four different preparations 
шеге found to be 0.9-1.1 residues/mole of product. When 
smaller amounts of the active ester шеге used the extent of 
the incorporation decreased; the presence of tryptophan in 
the product became undetectable шЬеп less than 5 equiv. of 
the active ester шеге used. The apparent decrease in the 
effective concentration may be due to some interaction of 
the reagent uith aromatic residues in the fragment (60-104) 
(16). 
After deprotection of the peptide derivative I by a 
very short treatment uiith a hard base, as previously des­
cribed (17,IB), the methionine sulfoxides in the peptide 
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Table иі.З.І.: Analytical details of Clsc-( L)-Xy z-DH. 
Xyz yield isolated R.p(a.) 
% as: M
D 
20 formula 
e l e m e n t a l a n a l y s i s 
C% H% N% 
T r p , ( 5 ) 
B f a 
B t a 
T r p ( 5 F ) 
T r p ( B F ) 
95 
94 
77 
87 
T r p ( t F ) f ( 1 4 ) 76 
D C A s a l t 0 . 2 B ( A ) - 5 . 4 0 ° C 2 7 H 4 1 M 3 0 6 5 6 0 . 4 2 7 . 8 S 7 . 8 3 
0 . 6 2 ( B ) c=1 t We0H 6 0 . 5 7 . 7 7 . θ 
D C A s a l t 0 . 4 9 ( A ) + 0 . 9 4 ° C ^ H ^ N ^ S 6 0 . 4 3 7 . 5 1 5 . 2 2 
0 . 6 5 ( B ) c = 0 . e 6 f M e O H 6 0 . 4 7 . 5 5 . 1 
A c i d 0 . 4 4 ( A ) - 1 6 . 8 5 ° Cj ^
 7 І \ І 0 Б 5 2 4 8 . 5 1 4 . 6 1 3 . 7 7 
0 . 6 7 ( B ) с = 0 . 8 3 , П е О Н 4 8 . 6 4 . 6 3 . 8 
D C A s a l t 0 . 2 6 ( A ) - 6 . 4 2 ° C 2 7 H 4 0 F [ \ 1 3 G 6 S · 1 / 4 H 2 0 5 8 . 0 9 7 . 3 2 7 . 5 3 
0 . 6 4 ( B ) c=1.23,|Y|eGH 5 8 . 1 7 . 2 7 . 5 
D C A s a l t 0 . 3 1 ( A ) - 5 . 8 ° C ^ H ^ F I ^ O g S · 1 / 2 H 2 0 5 7 . 6 2 7 . 3 5 7 . 4 7 
0 . 7 9 ( B ) c = 1 , M e 0 H 5 7 . 6 7 . 1 7 . 3 
D C A s a l t 0 . 6 8 ( B ) - 0 . 2 0 ° C ^ H ^ F ^ O g S 5 3 . 5 5 5 . 8 3 6 . 9 4 
c=1,meOH 5 3 . 2 5 . 9 7 . 0 
a. System A: chloroform-methanol-acetic acid (95:20:3) 
System B: 1-butanol-acetic acid-uater (4:1:1) 
b. Upper values are calculated 
Table MI,3,2.: Analytical details of Wsc-(L)-Xyz-OtCp. 
Xyz 'ield m.p.0C Rf(a.) [a]
1 D 
20 formula elemental analysis 
C% H% N% 
c . 
T r p 75 1 9 0 Ο - 1 9 1 ο 0 . 7 4 ( д ) - 3 6 . 6 ° C^H 
Q . B 2 ( B ) c=1.3,D|viF 
B f a 68 1 5 3 0 - 1 5 4 D 0 . 7 7 ( A ) - 3 7 . 2 ° C^H 
0 . 8 6 ( B ) c = G . 7 1 t D M F 
B t a 72 1 5 9 α - 1 6 0 ο O . B 1 ( A ) - 4 2 . 3 ° C^H 
O . B B ( B ) c=1.3 f D|viF 
T r p ( 5 F ) 73 1 7 0 ο - 1 7 1 Ο 0 . 7 1 ( A ) - 2 B . 9 0 C^H 
G . B 1 ( B ) c = 1 . 0 5 t D I 4 F 
T r p ( 6 F ) 51 1 4 4 a - 1 4 6 0 0 . 7 9 ( A ) - 2 9 . 0 ° C ^ H 
0 . 7 6 ( B ) c = 0 . 6 2 ( D M F 
T r p ( t F ) d · 61 1 6 9 α - 1 7 1 α 0 . 4 3 ( D ) - 4 4 . 5 ° C ^ H 
c = 1 , A n b . 
9 C 1 3 N 2 0 6 S 
8 C 1 3 N 0 7 3 
3 C 1 3 N D 6 S 2 
3РС1-,І\І_0С3 i o ¿ Ь 
ÌFC13K2DBS 
5 4 3 2 6 
4 7 . 2 5 3 . 5 9 5 . 2 5 
4 7 . 3 3 . 5 5 . 3 
4 7 . 1 6 3 . 3 9 2 . 6 2 
4 7 . 3 3 . 5 2 . 6 
4 5 . 7 9 3 . 2 9 2 . 5 4 
4 5 . В 3 . 2 2 . 6 
4 5 . 7 1 3 . 2 9 5 . 0 8 
4 5 . 0 3 . 3 5 . 0 
4 5 . 7 1 3 . 2 9 5 . 0 8 
4 5 . 7 3 . 4 5 . 0 
4 1 . 6 3 2 . 5 0 4 . 6 2 
4 2 . 0 2 . 8 4 . 8 
a. System A: chloroform-methanol-acetic acid (95:20:3) 
System В: 1-butanol-acetic acid-uater (4:1:1) 
System D: chloroform-methanol (9:1) 
b. The abbreviation An denotes acetone 
c. Upper values are calculated 
d. See réf.(14) 
derivative II could шеіі be reduced by treatment with aqueous 
mercaptoacetic acid (19,2D,21) which has proven to be a very 
efficient reducing agent for sulfoxides in proteins (22). 
Amino acid analyses of III after alkaline hydrolysis (15^ 
aqeous NaOH, 1Б h at 105oC), showed that only a small amount 
(ca 10%) of the sulfoxide groups had escaped the reductive 
treatment. 
In Chapter III (fig. III.3.2.) it has been shown that 
the absorption spectra between 250 and 730 nm. of a solution 
of the heme peptide (1-38) in the oxidized and in the reduced 
form are changed by the addition of the non-heme peptide 
(39-104); the absorption at 550 nm. increases until the molar 
ratio of the non-heme peptide and ferro heme peptide is unity 
(see also ref. 1 ). Fig. VI.3.1. shows that the interaction 
between the non-heme peptide (59-104) (III) and the ferro 
heme-bearing peptide (1-3B) proceeds quite similar; a 1:1 
complex is formed also in this case. 
The oxidized forms of the two complexes differ, however, 
in the position of the Soret band in the visible part of the 
spectrum. In the novel complex (1-38):(59-104) the Soret 
maximum occurs at 406 nm, whereas the Soret band of the com­
plex, composed of complementary fragments (1-38):(39-104) is 
at the same position as that of native cytochrome c, viz. at 
409 nm. This difference is not found in the reduced complexes; 
both have a maximum at 415 nm., the same as for cytochrome c. 
The shift of the Soret band in the oxidized form to shorter 
wavelength (406 nm.) has been associated earlier with an 
axial ligation of the ferri heme iron atom with two nitro­
gen atoms in cytochrome с (23). However, the (1-3B):(59-104) 
ferri peptide complex possesses a normal shaped absorption 
band at 695 nm., which should be indicative of an iron-sulfur 
ligation, implying the sulfur atom of methionine-ΘΟ. So, 
the position of the Soret maximum at 406 nm. seems not un­
ambiguously correlated to a deviating axial ligation of the 
ferri heme atom. 
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Fig. UI.3.1. Spectral titrations of the heme peptide 
(1-3B) with some non-heme peptides. HP: heme peptide; 
NHP: non-heme peptide; conditions as described in 
Chapter III. 
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The optical density at 695 nm. of the complex (1-38): 
(59-104) is not much 1ошег(84/$) than that of natiwe cyto­
chrome c. Presently there is no explanation for the obser-
uations of Parr et al. (24) who describes the (1-38):(56-104) 
complex as being endoued with only a very uieak absorption 
band at 695 nm. 
When the complexation of the heme peptide (1-38) is 
performed with the bisoxide II the a- and ß-absorption 
bands in the uisible part of the spectrum of the ferro com-
plex also increase, but the spectral titration suggests that 
a small excess of the non-hemc peptide is necessary in order 
to giue a 1:1 complex (fig. UI.3.1.). Houever, the ferri-
form of the ensueing complex does not exhibit a 695 nm. ab-
sorption band as can be expected for a complex containing 
oxidized methionine residues. This contradicts the suppo-
sition of UJilgus et al. (25) that changes in the uisible 
region of the absorption spectrum of ferro heme peptides 
are indicative of the occurence of iron-sulfur ligation. 
As was outlined already in Chapter III, the process of 
ascorbate reduction requires an intact region of the protein 
in the neighbourhood of arginine-38, at the lower side of 
the heme group (26). This part of the molecule corresponds 
to the deliberately removed sequence in the complex (1-38): 
(59-104), Therefore it is not surprising that upon reduction 
of this complex with L-ascorbic acid, the concomitant rise 
of the α-band in the absorption spectrum is confined to 42^ 
of the maximum value (achieved with dithionite). If, for 
comparison the complex (1-38):(39-104) is reduced with 
L-ascorbic acid, the α-band reaches a level that is 79% of 
the maximum value. 
Chromatography of a mixture of III and an excess of 
the heme-containing fragment, resulted in the formation of 
two red coloured peaks (fig. UI.3.2.); a large peak repre­
senting the 1:1 complex of the fragments (1-38) and (59-104) 
and a smaller one corresponding to the excess of the heme 
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peptide. A similar result uias obtained on chromatography 
of a mixture of the reduced fragment (60-104) and the heme 
peptide (1-38). 
0,03 
k280nm. 
0.03-
Ю0 
Elution volume (ml.) 
Fig. UI.3.2, Chromatography on Sephadex G-50 fine in 
0.01 И NaCl of a mixture of fragment (59-104) and 
excess fragment (1-38) (A) and of fragment (1-38) (B). 
The complexation of these fragments also results in an in­
crease of the α-and ß-absorption bands (fig. VI.3.1.) but 
the ferri complex does not exhibit an absorption maximum 
at Б95 nm.t although methionine-80 is present in the un-
oxidized thio-ether form. This experiment is in accord with 
the suggestion of Myer et al. (27), uhich correlates the 
stability of the iron-sulfur ligation with the formation of 
a native tryptophyl-heme domain. Addition of the fragment 
(39-59) (see Chapter II) to a solution of the complex (1-38): 
(60-104) did not change the absorption at 695 nm. 
Evidently, the tryptophan-heme domain, which is necessa­
ry for the iron-sulfur ligation, can only be established 
when the tryptophyl residue 59 is a component of the methio-
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nine-80 containing peptide. The absence of a 695 nm. absorp­
tion band in the spectrum of the previously described (28) 
noncovalent complex (1-65):(66-104) is consistent with this 
idea. This hypothesis implies that cleavage of cytochrome с 
at any residue located at the C-terminal side of tryptophan-
59 leads to fragments from uhich no properly functioning 
complex can be derived. Furthermore, the results described, 
support the recently proposed idea that a productive nonco­
valent complex from cytochrome с fragments is the result 
of at least tuo steps in the folding of the peptides (29), 
In the former step, involving tryptophan-59, the tryptophan-
heme domain is established. This triggers the second step in 
uihich the sulfur atom of methionine-80 is ligated to the 
heme iron atom. 
The thermostability of the protein structure tends to 
decrease if the chain lengths become smaller. This is mani­
fested by an increased thermolability of the absorption band 
at 695 nm. (fig. UI.3.3.). The disappearance of this band is 
completely reversible, as it is for cytochrome c. 
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Fig. UI.3.3. Temperature 
dependence of the 695 nm 
absorption band of cytochrome 
с (·), (l-38):(39-104) pep­
tide complex (o) and (1-38): 
(59-104) peptide complex ( a). 
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In order to study the biological activity of the non-
covalent complex (1-38):(59-104), the preparation and pro­
perties of which haue been described in this chapter, the 
rate of electron transfer from cytochrome c-reductase to the 
complex as uell as the rate of electron transfer from the 
complex towards cytochrome c-oxidase can be measured. Until 
nouj, only the activ/ity towards the oxidase has been inves­
tigated. The complexes (1-38):(59-104), containing the tryp­
tophan analogues, depicted in fig. \/I.1.2., шеге also tes­
ted for their ability to transfer an electron to cytochrome 
c-oxidase. These modified complexes шеге prepared in the 
same шау as described for the complex containing the unmo­
dified tryptophan residue. The results of these activity 
measurements are compared with those of the complex (1-38): 
(60-104), lacking the tryptophan residue, the complex (1-38): 
(39-104), described in Chapter III, and native cytochrome c. 
It is known that two binding sites for cytochrome с are 
present on the oxidase, a high affinity and a low affinity 
site. Measurements of the rates of electron transfer to cyto­
chrome с oxidase were carried out, using the Polarographie 
method which yields mainly information about the high affi­
nity site (12,13). Under the conditions of this assay oxidase-
bound cytochrome c, which cannot be reduced by ascorbate, 
is reduced with tetramethyl-phenylenediamine (TMPD) at a rate, 
which is much larger than the rate of dissociation of the 
cytochrome c: oxidase complex. It has been demonstrated that 
in the steady state oxidase-bound cytochrome с is nearly com­
pletely in the reduced form. In the Polarographie method the 
turnover rate is determined by measuring the oxygen uptake 
at various cytochrome с concentrations; the rate is propor­
tional to the amount of the cytochrome c: oxidase complex 
present. In plots of V/[cyt c] versus V (Eady-Hofstee plots) 
Km can be identified with the dissociation constant of the 
complex (Kß). І^ has been suggested that the maximal turn­
over rate (Umax) is determined by a relatively slow electron-
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transfer step uithin the oxidase (13). l/max-values cannot 
be found by extrapolation of the Eady-Hofstee plots, obtained 
from the Polarographie assay, because of the presence of a 
second (Ιοω affinity) site. At higher concentrations, elec­
tron transfer uia this second site causes an additional 
supply of electrons to the oxidase and leads to a decrease 
of the slope of the Eady-Hofstee plot. Therefore Umax may 
be larger than found by extrapolation. 
The Polarographie method, applied to modified cytochro­
me с deriuatiues, can certainly be used to determine the 
ability of such deriuatiues to transfer electrons to the 
oxidase. Houever, mutual comparison of test results of cyto­
chrome с and the deriuatiues is only useful, if all compounds 
bind to the same binding site on the oxidase. This may be 
assumed шЬеп the tertiary structures of the compounds are 
comparable and the essential elements of the active site of 
cytochrome с ( some positiuely charged lysyl residues at 
the left-top side of the front surface of the molecule (13)) 
are present. Although, many physical methods can yield in­
formation about aspects of the tertiary structures of modi­
fied cytochrome с deriuatiues, a close correspondance to the 
native structure of cytochrome с can only be established by 
N.n.R.-spectroscopy. At the present it was not possible to 
measure the MMR spectra of the novel complexes described in 
this chapter. Ноше ег, it could be established, using uisible 
spectroscopy, that in all complexes, containing tryptophan 
or a tryptophan analogue, uiith exception of the complex hol­
ding the benzothienylalanyl residue at position 59, the heme-
iron atom is ligated ujith the methionine-BO sulfur atom. 
In addition, the complexes are composed of tuo fragments 
which contain all essential, oxidase-binding elements of the 
binding domain on cytochrome c. Therefore, it may be specu­
lated that the binding of the complexes to the oxidase (with 
exception of the Bta-complex) occurs in a more or less simi­
lar fashion. 
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liJhen this supposition is correct, Eady-Hofstee plots 
may only be used to compare affinities (K
n
) to the oxidase, 
if the Km-ualues measured for the noncoualent complexes, 
can be equated to K
n
-values. There are a number of arguments, 
houjeuer, by iijhich this equalization can not be made in ad­
vance. It appears that the noncoualent complexes are less 
stable compared ujith cytochrome c, as judged from the tem­
perature dependence of the absorption band at 695 nm. More-
ouer, the modifications might cause a significant decrease 
of the redox potentials of the complexes, by uihich the re­
duction of oxidase-bound complex by TMPD might proceed slo­
wer and incomplete. Taking these considerations into account, 
only preliminary conclusions can be drawn from the biological 
actiwity measurements. 
Fig. VI.3.4. shows Eady-Hofstee plots for the reaction 
of cytochrome c-oxidase with cytochrome c, the complex (1—38): 
(39-104), the complex (1-38):(59-104), and the complex (1-38): 
(60-104), lacking the tryptophan residue. Addition of the 
complex (1-3B):(59-104) to the test system leads already 
at low concentrations to a rapid oxygen uptake. However, to 
reach a distinct rate of oxygen uptake larger amounts of the 
complex than of cytochrome с are necessary. Apparently, the 
steady state concentration of the oxidase-bound complex con­
taining iron in the ferro form is lower than with cytochrome 
с under the same conditions. In this sense, the complex is 
less active. It is not clear whether the cause of the lower 
activity lies in a lower affinity (larger K
n
) , increased 
lability, or a slower reduction by TMPD. 
The activity of the complex (1-38):(60-104) differs 
from that of the individual fragments (1-38) and (60-104) 
which are completely inactive, but is very low, indicating 
that the introduction of tryptophan -59 is attented with a 
considerable increase of the biological activity. 
The complex (1-38):(39-104) causes a more rapid up­
take of oxygen than cytochrome с at all concentrations mea-
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sured. An explanation might be that the affinities of this 
complex for the tuo binding sites on the oxidase are nearly 
equal so that the electron transport, euen at Ιοω concentra­
tion of complex, can take place via both binding sites, in­
creasing the rate of oxygen uptake. It has been shown (13) 
that the Іошег affinity of cytochrome с for the second bin­
ding site is caused mainly by electrostatic interaction be­
tween the entering, second molecule and that already present 
at the high affinity site. Lysyl residue 39 should be invol­
ved in this interaction, because inversion of the positive 
charge at this residue by the introduction of a carboxydi-
nitrophenyl (CDIMP) group leads to a large increase of the 
affinity for the second site, whereas corresponding modifi­
cations of other lysyl residues do not lead to a similar 
offect. In the complex (1-3B):(39-104) the lysyl residue 39 
38 is present but it might be that the splitting of the Arg -
39 Lys peptide bond induces a conformational change around 
lysine -39 so that the tertiary structure of this part of 
the molecule is no longer comparable with that of cytochrome 
c. One might speculate that also in this case a high affini­
ty for the second binding site is attained. 
Fig.VI.3.4. Eady-Hofste 
plots for the reactions 
of cytochrome c-oxidase 
with cytochrome с (·), 
(1-3B):(39-104) peptide 
complex (o), (1-38): 
(59-104) peptide compie 
(D) and (1-38):(60-104) 
peptide complex (*); 
\l is expressed as pmol 
0_·sec 
Fig, UI. 3.5. shoiijs Eady-Hofstee plots for the reaction 
of cytochrome c-oxidase ijjith the series of complexes (1-38): 
(59-104) in uhich position 59 is occupied by a tryptophan 
analogue (see Fig. UI.1.2,). The main conclusion is that all 
these complexes show a rather high activ/ity. Small changes 
in the indolyl side chain of residue 59, introduction of a 
fluorine atom at C5 or C6, cause only a small decrease of the 
activity uihereas introduction of four fluorine atoms (C4-C7) 
giues an analogue with a somewhat higher actiuity. Apparently, 
the activity of the complexes depends only little on the dis­
tribution of charge in the aromatic side chain of residue 59. 
Replacement of the NH-function of the indolyl side chain 
eliminates the ability of residue 59 to participate in the 
hydrogen bonding, present in cytochrome с betueen this residue 
and the inner propionic acid residue of the heme group. It is 
remarkable that the complex, containing a benzofuryl-alanine 
residue at position 59,still possesses a distinct activity, 
though it is louer than that of the tryptophan containing com­
plex. Hotuever, the most conspicuous result is given by the 
complex, containing the benzothienyl-alanine residue. This 
complex is not only unable to contribute to hydrogen bonding 
betueen the heme group and residue 59 but the absence of a 
695 nm absorption band in the visible region of the spectrum, 
points also to the absence of the normal iron-sulfur ligation 
betueen the heme group and methionine -80. Even this complex 
still shows a Ιοω but clear activity. 
From these considerations and measurements it is clear 
that, in order to gain more insight into the role of trypto­
phan 59 in cytochrome c, additional experiments are necessary 
such as, N.M.R. studies, binding experiments of the complexes 
with the oxidase, determination of pre-steady state kinetics 
of the oxidase reaction and lastly the investigation of the 
biological activity towards cytochrome-c-reductase. 
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Fig. VI.3.5. Eady-Hofstee plots for the reaction of 
cytochrome c-oxidase uith native cytochrome с ( D ) , 
complex (1-3Θ):(59-104) (*), (1-38):([Bfa]59-(59-104)) 
(V), (l-38):([Bta]S9-(59-104)) (•), (1-3B):([Trp(5F)]59-
(59-104) )) (O), (1-38):([Trp(6F)]59-(59-104)) (·), 
(l-38):( [Trp(tF)]59-(59-104)) (*) and (1-38):(60-104) 
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SAMENVATTING 
Een groot gedeelte van het onderzoek dat beschreuen is 
in deze dissertatie handelt over de vorming en de eigenschap­
pen van molecuul-complexen, шеіке verkregen kunnen ujorden 
uit fragmenten van cytochroom с die zelf biologisch inactief 
zijn. De onderzochte complexen zijn steeds opgebouud uit twee 
fragmenten; in een geval bevat het complex de gehele amino­
zuursequentie van cytochroom c, in de andere gevallen ont­
breekt een relatief klein gedeelte daarvan. In een van de 
laatstgenoemde complexen is op een specifieke ujijze п ami­
nozuur vervangen door een aantal analoga van dat aminozuur 
om het effect van deze modificatie op de biologische activi­
teit te onderzoeken. 
In het inleidende hoofdstuk wordt een beknopte samen­
vatting gegeven van hetgeen over de structuur en functie 
van cytochroom с bekend is. In dit hoofdstuk worden ook enke­
le aspecten van de eiuiit-semisynthese besproken en met voor­
beelden toegelicht; tenslotte wordt een overzicht gegeven 
over molecuulcomplexen uit eiwitfragmenten. Aan het slot van 
dit hoofdstuk wordt het doel van het onderzoek geformuleerd. 
Aan ons onderzoek ligt de gedachte ten grondslag dat modifi­
caties aan het enige en invariante tryptophaan residu, dat 
in paardehart cytochroom с in positie 59 voorkomt, wellicht 
inzicht zou kunnen verschaffen in de betekenis van dit ami­
nozuur voor de werking van het enzym. De opzet van het onder­
zoek was om enkele gemodificeerde cytochromen с te maken waar­
in tryptophaan 59 was vervangen door een analoog aminozuur, 
via een nieuw te ontwikkelen semisynthese van cytochroom c. 
Dm geschikte fragmenten te verkrijgen voor een derge­
lijke semisynthese werden, zoals beschreven in hoofdstuk II, 
een aantal enzymatische en chemische fragmentatie methoden 
toegepast op cytochroom c, nadat eerst de 19 ε-amino functies 
beschermd waren met de methylsulfonylethyloxycarbonyl-CWsc)-
groep. De onderzochte fragmentaties betroffen klievingen 
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gericht op de residuen arginine-38f tryptophaan-59 en me-
thionine-B5. De resulterende fragmenten (1-38), (1-65), 
(39-65), (39-59), (39-104), (66-104) en (60-104) konden 
goed gezuiverd en gekarakteriseerd worden. Het bleek dat de 
gebruikte aminobeschermfunctie stabiel is onder de condities 
van de splitsingen, zelfs onder de uiterst zure omstandig­
heden benodigd uoor de oxidatieve klieving achter trypto­
phaan-59. 
In hoofdstuk III is de ontscherming van de beide tryp-
tische fragmenten (1-38) en (39-104) van cytochroom с be­
schreven, en is de mogelijkheid onderzocht om een niet cova-
lent gebonden complex te vormen uit deze twee fragmenten. 
De spontane vorming van een dergelijk complex met een nage­
noeg natieve conformatie zou van beslissende betekenis kun­
nen zijn bij het gebruik van deze fragmenten in een semisyn-
these шаагіп het herstel van de Arg -Lys binding de laatste 
stap is. De beide fragmenten blijken inderdaad een biologisch 
actief complex te vormen dat in vele opzichten lijkt op na-
tief cytochroom c. 
De koppeling van deze complementaire tryptische fragmen­
ten stuitte echter op een aantal practische problemen, waar­
van de selectieve activering van de terminale a-carboxyl-
groep in het fragment (1-38) een van de grootste is. Het ge­
bruik van een proteolytisch enzym als katalysator voor de syn­
these van een peptide band zou een mogelijke oplossing voor 
dit probleem kunnen zijn. Daarom werd een model onderzoek ver­
richt naar de bruikbaarheid van trypsine om de twee trypti­
sche fragmenten (1-38) en (39-104) covalent te recombineren 
tot cytochroom c. Uit dit model onderzoek, dat beschreven is 
in hoofdstuk IV, blijkt dat deze enzymatische methode goed 
te gebruiken is voor de synthese van kleinere peptiden zo­
als ACTH-(7-10)-tetrapeptide en ook voor de condensatie van 
een klein synthetisch model dipeptide met het grotere frag­
ment (1-38) uit cytochroom c. Pogingen om een enzymatische 
koppeling uit te voeren van dit laatste peptide aan grotere 
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fragmenten boden echter geen perspectief. 
In deze fase van het onderzoek werd besloten de oor­
spronkelijke opzet om de beide tryptische fragmenten van cy-
tochroom с covalent te koppelen, te staken en het onderzoek 
voort te zetten met een studie naar de vervanging van tryp-
tophaan in niet covalent gebonden complexen van cytochroom 
с fragmenten. 
De meest eenvoudige methode om het effect van dergelijke 
vervangingen te onderzoeken, leek het gebruik van een complex 
waarin de sequentie (39-58) opzettelijk is uieggelaten. Dit 
gedeelte van de sequentie van cytochroom с komt in de ter­
tiaire structuur voor als een flexibele lus aan de buitenkant 
van het molecuul en in cytochroom c551 van Pseudomonas aeru­
ginosa is dit fragment van de aminozuurvolgorde zelfs afwezig, 
Als het complex, bestaande uit de fragmenten (1-3Θ) en (59-
104), biologische actief zou blijken te zijn, zou een serie 
van fragmenten (59-1D4), die gevarieerd zijn op plaats 59, 
bereid kunnen ujorden om deze vervolgens te complexeren met 
het fragment (1-3Θ). 
In hoofdstuk \l is een strategie beschreven voor de semi-
synthese van het fragment (59-104), die berust op een azide-
koppeling tussen een synthetisch, partieel beschermd hexapep-
tide (59-64) en het veel grotere selectief beschermde frag­
ment (65-104). Het bleek echter dat deze koppeling niet kon 
worden gerealiseerd. Daarom uierd een andere strategie voor 
de bereiding van het fragment (59-104) opgesteld, die beschre­
ven is in hoofdstuk UI. Hierin wordt gebruik gemaakt van het 
selectief beschermde fragment (60-104) dat verlengd wordt met 
tryptophaan. 
Het aldus verkregen fragment (59-104) bleek, ondanks de 
deletie van de sequentie (39-58), een redelijk stabiel en 
biologisch actief complex te vormen met het heemfragment (1-38¡ 
Dit complex bleek een goed uitgangspunt te bieden voor een 
studie naar het effect van tryptophaan vervangingen, omdat een 
complex, bestaande uit de fragmenten (1-38) en (60-104) bio-
147 
logisch inactief was, 
In dit onderzoek is allereerst de inuloed onderzocht 
van kleine veranderingen in de hydrophobiciteit van- en de 
ladingsverdeling in de indol ring. Daarom werden tuee mono-
fluorderivaten en een tetrafluordcriuaat van tryptophaan 
geïntroduceerd op plaats 59. Het bleek dat deze substituties 
nauujelijks invloed op de reactiviteit van de complexen met 
cytochroom с oxidase hadden. De substitutie van tryptophaan 
door twee analoga die de mogelijkheid missen om een H-brug 
te vormen uitgaande van de indolyl-NH groep, omdat deze ver­
vangen is door een zuufstof of zwavel atoom, leidt шеі tot 
een lagere activiteit ten opzichte van het oxidasejmaar inte­
ressant is dat ook deze complexen nog een significante biolo­
gische werkzaamheid vertonen in de gebruikte testmethode. 
Het meest opmerkelijke resultaat wordt veroorzaakt door 
het analogon dat een zwavel atoom bevat in de plaats van de 
indolyl-[\JH groep; ondanks het feit dat de tertiaire structuur 
van dit analogon zeker afwijkt van de natieve structuur kon 
ook voor dit analogon een duidelijke biologische activiteit 
gemeten worden. 
Om de gemeten verschillen in biologische activiteiten 
onderling goed te kunnen interpreteren,moet echter vast staan 
dat de complexen wat betreft de structuur en het gedetailleer 
de mechanisme van de enzymatische oxidatie vergelijkbaar zijn 
met cytochroom c. Een studie naar de verschillen in confor-
matie van de complexen en de implicaties hiervan voor de in­
teractie met het oxidase lijkt daarom ook zinvol voor het vas 
stellen van de rol van tryptophaan 59 in cytochroom c. 
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